JPH0898690A - Production of gene bank using new cosmid vector - Google Patents

Production of gene bank using new cosmid vector

Info

Publication number
JPH0898690A
JPH0898690A JP9511794A JP9511794A JPH0898690A JP H0898690 A JPH0898690 A JP H0898690A JP 9511794 A JP9511794 A JP 9511794A JP 9511794 A JP9511794 A JP 9511794A JP H0898690 A JPH0898690 A JP H0898690A
Authority
JP
Japan
Prior art keywords
dna
solution
precipitate
reaction mixture
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9511794A
Other languages
Japanese (ja)
Inventor
Masahiro Ishiura
正寛 石浦
Hiroshi Ohashi
博 大橋
Yoshio Okada
善雄 岡田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority to JP9511794A priority Critical patent/JPH0898690A/en
Publication of JPH0898690A publication Critical patent/JPH0898690A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE: To provide a method for simply and efficiently obtaining a gene bank of extraneous DNA using a cosmid vector prepared by using a gene manipulation technique. CONSTITUTION: Various extraneous DNA fragments having 35-45Kbp lengths are inserted between a light arm and a left arm each having at least 3 cos of lambda phage or lambdoid phase having a same direction obtained by cleaving with two kinds of restriction enzymes and each having at least one or two cos, and the each fragment is changed into transduced phage particles by in vitro packaging and cloned into Escherichia in which lambda phase is lysogenized, and then induced, and the recombinant DNA is changed into transduced phage particles by vivo packaging to produce a gene bank of the extraneous DNA.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は遺伝子操作技術に関し、
さらに詳しくは遺伝子操作技術を使つて作成した新規コ
スミドベクターを用いる遺伝子バンクの製造法に関す
る。
FIELD OF THE INVENTION The present invention relates to gene manipulation technology,
More specifically, it relates to a method for producing a gene bank using a novel cosmid vector prepared by using a gene manipulation technique.

【0002】[0002]

【従来の技術】ヒトをはじめとする哺乳動物の遺伝子の
大きさは20キロ塩基対(以下、キロ塩基対をKbpと
略す)を越えるものが少なくない。現在、広く使われて
いるラムダベクターにクローン化できるDNAの大きさ
は20Kbpなので、これより大きい遺伝子全体を機能
のある形でクローン化することはできない。
2. Description of the Related Art The gene size of mammals including human is often over 20 kilobase pairs (hereinafter, kilobase pairs are abbreviated as Kbp). Since the size of the DNA that can be cloned into the widely used lambda vector at present is 20 Kbp, it is not possible to clone a gene larger than this in a functional form.

【0003】ラムダフアージのcohesive en
d site(以下cosと略す)を有するベクター、
すなわちコスミドベクターを使えば35〜45Kbpの
大きさのDNAをクローン化できる。種々のベクターの
中で、コスミドベクターが最も大きい長さのDNAをク
ローン化できるが、長いゲノムDNAの調製がむずかし
いことや、インサートのないベクターだけのバツクグラ
ンドが高いこと、また効率が良くないことなどが障害に
なつて、コスミドベクターの利用は進まなかつた。とこ
ろが、〔イシユ−ホロウイツツ アンド バーク(Is
h−Horowicz & Burke)〕は、ホスフ
アターゼを利用してベクターに方向性を持たせる工夫を
し、ベクターだけのバツクグランドの値を下げるととも
にクローン化の効率を上げることに成功した〔デー・イ
シユ−ホロウイツツ アンド ジエー・エフ・バーク:
ヌクレイツク アシツズ リサーチ(D.Ish−Ho
rowicz & J.F.Burke,Nuclei
c Acids Res.),,2889(198
1)〕。
Lambda Fuerge cohesive en
a vector having d site (hereinafter abbreviated as cos),
That is, a cosmid vector can be used to clone a DNA having a size of 35 to 45 Kbp. Of the various vectors, the cosmid vector can clone the longest DNA, but it is difficult to prepare a long genomic DNA, the background of only the vector without insert is high, and the efficiency is not good. As a result, the use of cosmid vectors has not progressed. However, [Ishiyu-Hello It's and Burke (Is
h-Horowicz & Burke)] has succeeded in lowering the background value of only the vector and increasing the cloning efficiency by devising a vector having directionality by using phosphatase. Hollow It's and JF Burke:
Nucleic Acids Research (D.Ish-Ho
rowicz & J.M. F. Burke, Nuclei
c Acids Res. ), 9 , 2889 (198)
1)].

【0004】イシユ−ホロウイツツ アンド バーク
(Ish−Horowicz & Burke)法によ
るゲノムDNAの遺伝子バンクの製造法は以下のとおり
である(たとえば、現在、広く使われているコスミドベ
クターの1つであるpJB−8を例にとる)。pJB−
8は5.44Kbpの大きさで、制限酵素BamHI、
HindIII ,Sa1Iでそれぞれ1カ所切断され、ラ
ムダフアージのcosを1個有するコスミドベクターで
ある。
The method for producing a gene bank of genomic DNA by the Ishi-Horowitz & Burke method is as follows (for example, pJB- which is one of the cosmid vectors widely used at present). 8 as an example). pJB-
8 has a size of 5.44 Kbp and has a restriction enzyme BamHI,
It is a cosmid vector having one lambda cos cos which is cleaved at each of HindIII and Sa1I.

【0005】(1)pJB−8をHindIII で切断す
ることによつて直線状DNAとし、次に、ホスフアター
ゼ処理によつてHindIII の切断片を不活化する。そ
して、BamHIで切断することによつて2個のDNA
断片が得られ、cosを含む大きなDNA断片(5.4
Kbp)をアガロースゲル電気泳動法によつて単離す
る。得られたcosを含むDNA断片(5.4Kbp)
が、ラムダフアージの左腕に相当する。
(1) pJB-8 is cleaved with HindIII to give a linear DNA, and then a HindIII fragment is inactivated by phosphatase treatment. Then, by cutting with BamHI, two DNAs were obtained.
A fragment was obtained, containing a large DNA fragment containing cos (5.4
Kbp) is isolated by agarose gel electrophoresis. The obtained cos-containing DNA fragment (5.4 Kbp)
However, it corresponds to the left arm of Lambda Fuaj.

【0006】(2)pJB−8をSalIで切断するこ
とによつて直線状DNAとし、次にホスフアターゼで処
理することによつてSalIの切断片を不活化する。そ
して、BamHIで切断することによつて2個のDNA
断片が得られ、cosを含む小さなDNA断片(2.3
4Kbp)をアガロースゲル電気泳動法によつて単離す
る。得られたcosを含むDNA断片(2.34Kb
p)が、ラムダフアージの右腕に相当する。
(2) pJB-8 is cut with SalI to give a linear DNA, and then treated with phosphatase to inactivate the cut piece of SalI. Then, by cutting with BamHI, two DNAs were obtained.
A fragment was obtained, containing a small DNA fragment containing cos (2.3
4 Kbp) is isolated by agarose gel electrophoresis. The obtained DNA fragment containing cos (2.34 Kb
p) corresponds to the right arm of Lambda Fuge.

【0007】(3)たとえば、ヒトのゲノムDNAを制
限酵素Sau3AもしくはMboIで部分的に切断し、
35〜45Kbpの大きさのDNA断片を分画する。こ
の35〜45Kbpの大きさのDNA断片を、(1)と
(2)で別々に調製した左腕と右腕との間に、連結酵素
(T4−DNAリガーゼ)で挿入させて、組換え体DN
Aを調製する。 (4)組換え体DNAをin vitroパツケージン
グで形質導入フアージ粒子に変え、次いで大腸菌に感染
させることによりヒトのゲノムDNAの遺伝子バンクが
製造できる。
(3) For example, human genomic DNA is partially cleaved with a restriction enzyme Sau3A or MboI,
A DNA fragment with a size of 35 to 45 Kbp is fractionated. The DNA fragment having a size of 35 to 45 Kbp was inserted between the left arm and the right arm separately prepared in (1) and (2) with a ligation enzyme (T4-DNA ligase) to give a recombinant DN.
Prepare A. (4) A gene bank of human genomic DNA can be produced by converting the recombinant DNA into transduced phage particles by in vitro packaging and then infecting E. coli.

【0008】[0008]

【発明が解決しようとする課題】以上がイシユ−ホロウ
イツツ アンド バーク(Ish−Horowicz&
Burke)法によるゲノムDNAの遺伝子バンクの
製造法であるが、次の4つの問題点がある。第1に、p
JB−8はcosが1つしかなく、左腕と右腕とを別々
に調製しなければならない。第2に、左腕と右腕につい
て、それぞれcosを含むDNA断片をアガロースゲル
電気泳動で分離しなければならない。第3に、pJB−
8の左腕の長さは5.4Kbp、右腕の長さは2.34
Kbpであり、左腕と右腕との長さが異なるので、35
〜45KbpのゲノムDNAに連結する確率も異なり、
左腕と右腕の混合する比率を検討しなければならない。
第4に、この製造法で得られた遺伝子バンクにおいて
は、組換え体DNAは大腸菌内でプラスミドとして複製
し、大腸菌より共有結合で閉鎖された環状のプラスミド
DNA(ccc−DNA)として分離精製するが、組換
え体DNAを形質導入フアージ粒子としてゲノムDNA
の遺伝子バンクを製造することはできない。
The above is the description of Ishi-Horowicz & Burke.
The method of producing a gene bank of genomic DNA by the Burke method has the following four problems. First, p
JB-8 has only one cos, and the left arm and the right arm must be prepared separately. Second, DNA fragments containing cos must be separated by agarose gel electrophoresis for each of the left and right arms. Third, pJB-
8 has a left arm length of 5.4 Kbp and a right arm length of 2.34.
Since it is Kbp, and the lengths of the left arm and the right arm are different, 35
The probability of ligation to ~ 45 Kbp genomic DNA is also different,
The mixed ratio of left and right arms must be considered.
Fourthly, in the gene bank obtained by this production method, the recombinant DNA is replicated as a plasmid in Escherichia coli and separated and purified as a circular plasmid DNA (ccc-DNA) covalently closed from Escherichia coli. However, the recombinant DNA is used as a transduction phage particle to form a genomic DNA.
It is not possible to manufacture the gene bank of.

【0009】[0009]

【課題を解決するための手段】本発明者らは、これらの
課題を解決するために、同一の方向性を持つたラムダフ
アージまたはラムドイドフアージのcosを少なくとも
3個有し、2種類の制限酵素で切ることによつて得られ
る、cosを少なくとも1個もしくは2個持つた長さの
ほぼ等しい右腕と左腕とが等モルできることを特徴とす
る新規コスミドベクターを作成し、このコスミドベクタ
ーを用いることによつて外来DNA遺伝子バンクの製造
法を完成するに至った。
In order to solve these problems, the present inventors have at least three lambda or lamdoid charge cos having the same direction, and have two types of restrictions. Use of this cosmid vector to prepare a new cosmid vector characterized in that the right arm and the left arm having at least one or two cos and having almost the same length can be equimolar and obtained by cutting with an enzyme. As a result, the method for producing a foreign DNA gene bank was completed.

【0010】本発明に用いられるコスミドベクターは、
同一分子内に同一の方向性を持つた少なくとも3個のc
osが存在し、2種類の制限酵素で切ることによつて得
られる、cosを少なくとも1個もしくは2個持つた長
さのほぼ等しい右腕と左腕とが等モルできるので、右腕
と左腕とを別々に調製する必要がなく、アガロースゲル
電気泳動で分離する必要もない。さらに、右腕と左腕の
長さがほぼ等しいので、35〜45KbpのゲノムDN
AにT4−DNAリガーゼによつて連結される程度もほ
ぼ等しいと考えてよく、2種類の制限酵素で切断してで
きた右腕と左腕の等モル混合物を、そのまま35〜45
KbpのゲノムDNAと連結すれば、組換え体DNAの
半分が形質導入フアージ粒子に変わり得ることが期待で
きる。このように、本発明のコスミドベクターを用いれ
ば、35〜45KbpのDNA断片として、ゲノムDN
Aの遺伝子バンクをより簡単、かつより効率よく製造で
きる。
The cosmid vector used in the present invention is
At least 3 c's with the same orientation in the same molecule
os is present and can be obtained by cutting with two kinds of restriction enzymes. Since the right arm and the left arm having at least one or two cos and having almost the same length can be equimolar, the right arm and the left arm are separated. It does not need to be prepared in advance and need not be separated by agarose gel electrophoresis. Furthermore, since the lengths of the right arm and the left arm are almost equal, the genome DN of 35 to 45 Kbp is
It may be considered that the degree of ligation to A by T4-DNA ligase is almost equal, and an equimolar mixture of the right arm and the left arm formed by cutting with two kinds of restriction enzymes is directly used for 35 to 45
It can be expected that half of the recombinant DNA can be transformed into transduction pharage particles when ligated to the Kbp genomic DNA. As described above, when the cosmid vector of the present invention is used, a DNA fragment of 35 to 45 Kbp can be obtained as a genomic DNA.
The gene bank A can be manufactured more easily and efficiently.

【0011】そして、さらに本発明のベクターは、同一
分子内に同一の方向性を持つた少なくとも3個のcos
を有するので、組換え体DNAをin vitroパツ
ケージングで形質導入フアージ粒子に変え、大腸菌に感
染させると、組換え体DNAは大腸菌内で2個のcos
を持つたプラスミドDNAとして複製する。この段階で
は、プラスミドDNAとしての外来DNAの遺伝子バン
クであるが、ラムダフアージが溶原化している大腸菌を
宿主として用いた場合には、加温もしくは紫外線照射す
ると言つたような誘発をかけることにより、溶原化して
いたラムダフアージは溶菌化サイクルに入り、大腸菌内
でラムダフアージが増殖し、最終的に大腸菌が溶菌して
ラムダフアージ粒子が外へ出てくる。この時に、大腸菌
内で2個のcosを持つたプラスミドDNAとして存在
している組換え体DNAも、cosを2個持つているた
めにラムダフアージの頭の部分に取込まれて、in v
ivoパツケージングで形質導入フアージ粒子に変換さ
れる。このようにして、形質導入フアージ粒子として外
来DNAの遺伝子バンクを製造できる。
Further, the vector of the present invention comprises at least 3 coss having the same orientation in the same molecule.
Therefore, when the recombinant DNA is transformed into transduction pharage particles by in vitro packaging and infected with E. coli, the recombinant DNA contains two cos in E. coli.
Replicate as a plasmid DNA containing At this stage, it is a gene bank of foreign DNA as plasmid DNA, but when Escherichia coli in which lambda phage is lysogenized is used as a host, it is heated or irradiated with ultraviolet rays to induce it. The lysogenized lambda phage enters the lysis cycle, the lambda phage grows in E. coli, and finally the E. coli lyses and the lambda phage particles come out. At this time, the recombinant DNA, which is present in E. coli as a plasmid DNA having two cos, is also incorporated into the head portion of the lambda phage due to having two cos, so that in v
It is converted to transduced phage particles by iv packaging. In this way, a gene bank of foreign DNA can be produced as transduction phage particles.

【0012】哺乳動物の培養細胞への遺伝子移入におい
て、染色体を用いる方法は、プラスミドDNAやゲノム
DNAを用いる方法と比較すると、(1)遺伝子移入の
効率と頻度とが常に10倍から100倍高く、(2)安
定なトランスホーマント・クローンが多く得られる点で
優れている〔レーウイス、ダブリユー・エイチ、スリニ
バサン ピー・アール:ストケ エヌ アンド シミノ
ビツチ、エル:ソマトセル ジエネテイツクス(Lew
is,W.H.,Srinivasan,P.R.,S
tokoe,N.,& Siminovitch,
L、:Somat、cell Genet.,,33
3,(1980)〕。
In gene transfer into cultured mammalian cells, the method using chromosomes is (1) the efficiency and frequency of gene transfer are always 10 to 100 times higher than those using plasmid DNA or genomic DNA. , (2) It is excellent in that many stable transformant clones are obtained [Rewis, Doubly H, Sriniva Samp Earl: Stoke N and Simon Bitsch, El: Somatocel Geneetics (Lew)
is, W. H. Srinivasan, P .; R. , S
tokoe, N .; , & Siminovitch,
L ,: Somat, cell Genet. , 6 , 33
3, (1980)].

【0013】多分、このことは、染色体ではDNAがク
ロマチン・タンパク質で密に包み込まれたクロマチン構
造をとり、デオキシリボヌクレアーゼ(DNase)の
攻撃から守られていることと関係があると思われる。ま
た、密なクロマチン構造をとることによつて細胞への取
込みが容易になつているのかもしれない。しかし、染色
体のままではDNAを組換えることができず、また、実
験に必要なだけの大量の染色体を細胞から調製すること
も容易ではない。いま、ラムダフアージ粒子の構成に着
目すると、ラムダフアージのDNAは外被タンパク質に
よつて密に包込まれており、クロマチン・タンパク質に
包込まれている染色体DNAと状況がよく似ている。
Perhaps this is related to the fact that DNA has a chromatin structure in which chromosomes are densely packed with chromatin proteins and is protected from the attack of deoxyribonuclease (DNase). In addition, the dense chromatin structure may facilitate the uptake into cells. However, DNA cannot be recombined with a chromosome as it is, and it is not easy to prepare a large amount of chromosomes necessary for experiments from cells. Now, paying attention to the structure of lambda phage particles, the lambda DNA is closely packed by the coat protein, and the situation is very similar to that of the chromosomal DNA encapsulated in the chromatin protein.

【0014】また、ラムダフアージベクターを用いて、
DNA組換えでラムダフアージ粒子として遺伝子バンク
を作成する方法はすでに確立している。石浦らは、HS
V−1のTK遺伝子を組込んだラムダベクターChar
on4Aの組換え体(ラムダフアージ粒子)を用いて、
Ltk- 細胞へのHSV−1TK遺伝子の移入を検討し
たところ、(1)遺伝子移入の効率は10-5で、裸のD
NAそのままの場合に比べて1桁高いが、染色体による
場合に比べて1桁低い、(2)形質転換細胞のコロニー
はDNAで得られたものに比べて大きく、そのクローン
の多くは非選択培地でも安定に保たれると、予想どおり
の結果を得た〔イシウラ エム等:モレキユラー セル
ラー バイオロジー(Ishiura,M.,et a
l.,Mol、Cell.Biol.),,607
(1982)〕。
Further, using a lambda phage vector,
A method for preparing a gene bank as a lambda phage particle by DNA recombination has already been established. Ishiura et al.
Lambda vector Char incorporating the V-1 TK gene
Using the recombinant of on4A (lambda sphere particles),
When the transfer of HSV-1TK gene into Ltk cells was examined, (1) the transfer efficiency was 10 −5 , and naked D
NA is an order of magnitude higher than that of intact NA, but is one order of magnitude lower than that of chromosomal use. (2) Transformed cell colonies are larger than those obtained with DNA, and most of the clones are non-selective media. However, when it was kept stable, the expected result was obtained [Ishiura Em et al .: Morekiular Cellular Biology (Ishiura, M., et a.
l. , Mol, Cell. Biol. ), 2 , 607
(1982)].

【0015】しかし、ラムダベクターで作成した遺伝子
バンクでの本質的な問題点は、ラムダベクターにクロー
ン化できるDNAの大きさは最大20Kbpなので、目
的の遺伝子がこれより大きい場合には機能のある形でそ
の遺伝子をクローン化することができないことである。
そこで、本発明の少なくともcos3個持つたコスミド
ベクターは、35〜45Kbpの外来DNAをクローン
化できるとともに、形質導入フアージ粒子として遺伝子
バンクを製造できるという点で優れており、細胞への遺
伝子移入に大きな力を発揮するものと思われる。
However, the essential problem with the gene bank prepared with the lambda vector is that the maximum size of DNA that can be cloned into the lambda vector is 20 Kbp. That is, the gene cannot be cloned.
Therefore, the cosmid vector having at least 3 cos of the present invention is excellent in that it can clone a foreign DNA of 35 to 45 Kbp, and can produce a gene bank as a transduction phage particle, and thus it is great for gene transfer into cells. It seems to exert power.

【0016】本発明の新規コスミドベクターの1つであ
る、pTcosApr /ori/cmr /neor を図
1に示す。pTcosApr /ori/cmr /neo
r は、コスミドベクターであるpRH(−44)もしく
はpLH(+129)由来の同一方向性のあるcos3
個と〔ミワ アンド マツバラ、ジーン、Miwa&
Matsubara,Gene,20,267(198
2)〕、Tn903由来のネオマイシン耐性遺伝子(n
eor )〔オカ、スギサキ アンド タカナミ、ジヤー
ナル オブ モレキユラー バイオロジー(Oka,S
ugisaki & Takanami,J.Mol.
Biol.,147、217(1981)〕、pNT−
31由来のクロラムフエニコール耐性遺伝子(cmr
〔トミザワ アンド イトウ プロシーデイング オブ
ナシヨナル アカデミ オブサイエンシズ ユー・エス
・エー〔Tomizawa & Itoh,Proc.
Natl.Acad.Sci.U.S.A.),78
6096(1981)〕、pBR−327由来のアンピ
シリン耐性遺伝子(Apr )及び複製開始点(ori)
〔ソベロン、カバラビアス アンド ボリバー、ジーン
(Soberon,Cavarrubias & Bo
livar,Gene),,287(1980)〕と
からなる。大きさは4.9Kbpであり、制限酵素Cl
aI、BamHIによつてそれぞれ1カ所切断される。
本ベクターを用いるゲノムDNA(外来DNA)の遺伝
子バンクの製造法を示せば以下のようになる(図2)。
[0016] which is one of the novel cosmid vector of the present invention, showing the pTcosAp r / ori / cm r / neo r in FIG. pTcosAp r / ori / cm r / neo
r is cos3 having the same direction derived from pRH (-44) or pLH (+129) which is a cosmid vector.
Individual and [Miwa and Matsubara, Jean, Miwa &
Matsubara, Gene, 20 , 267 (198).
2)], a neomycin resistance gene derived from Tn903 (n
eo r) [Oka, Sugisaki and high waves, journal of Morekiyura Biology (Oka, S
ugisaki & Takanami, J. et al. Mol.
Biol. , 147 , 217 (1981)], pNT-.
Chloramphenicol resistance gene (cm r ) derived from 31
[Tomizawa and Ito Proceeding of National Academic Accidents of Sciences USA [Tomizawa & Itoh, Proc.
Natl. Acad. Sci. U. S. A. ), 78 ,
6096 (1981)], the ampicillin resistance gene from pBR-327 (Ap r) and origin of replication (ori)
[Soveron, Cavalrubias & Bo
Liver, Gene), 9 , 287 (1980)]. The size is 4.9 Kbp and the restriction enzyme Cl
It is cut at one place each by aI and BamHI.
The method for producing a gene bank of genomic DNA (foreign DNA) using this vector is as follows (FIG. 2).

【0017】(1)pDcosApr /ori/cmr
/neor をClaIで切断することによつて直線状D
NAとし、次に、ホスフアターゼ処理によつてClaI
の切断片を不活化する。そして、BamHIで切断する
ことによつて、それぞれcosを少なくとも1個もしく
は2個持つた長さがほぼ等しい右腕と左腕とを調製す
る。(2)外来DNAをSau3AもしくはMboIな
どで限定消化し、35〜45Kbpの大きさのDNA断
片を調製する。(3)35〜45KbpのゲノムDNA
断片を(1)で調製した左腕と右腕との間にT4−DN
Aリガーゼで挿入させて、組換え体DNAを調製する。
(4)組換え体DNAをin vitroパツケージン
グで形質導入フアージ粒子に変え、ラムダフアージが溶
原化している大腸菌に感染させる。(5)この形質導入
体DNAは、ベクター由来のApr、cmr とoriを
含むので、アンピシリンもしくはクロラムフエニコール
で選択することによつて、2個のcosを持つた組換え
体DNAをプラスミドとして持つ大腸菌のみを選択的に
生かすことができる。(6)次に、トランスホーマント
(大腸菌)に、加温もしくは紫外線照射すると言つたよ
うな誘発をかけて溶原化していたラムダフアージを溶菌
化サイクルに移行させることによつて、2個のcos持
つた組換え体DNAをin vivoパツケージングで
形質導入フアージ粒子に変換できる。この形質導入フア
ージ粒子内には、1個のcos及びAp r 、ori、外
来DNAからなる組換え体DNAが包込まれている。こ
のようにしてゲノムDNA(外来DNA)の遺伝子バン
クを形質導入フアージ粒子として製造することができ
る。
(1) pDcosApr/ Ori / cmr
/ NeorA linear D by cutting with ClaI
NA and then ClaI by phosphatase treatment
Inactivate the cut pieces of. Then cut with BamHI
Therefore, at least one cos
Prepares a right arm and a left arm with two equal lengths
It (2) Foreign DNA such as Sau3A or MboI
Digestion with limited digestion and digestion of DNA with a size of 35-45 Kbp
Prepare pieces. (3) 35-45 Kbp genomic DNA
The fragment prepared in (1) was used for T4-DN between the left and right arms.
Recombinant DNA is prepared by insertion with A ligase.
(4) Recombinant DNA in vitro packaging
Change into transduction phasic particles and melt the lambda pharge.
Infect the E. coli that has been prototyping. (5) This transduction
Body DNA is Ap derived from vectorr, CmrAnd ori
As it contains ampicillin or chloramphenicol
Recombination with two cos by selecting in
Select only Escherichia coli that has body DNA as a plasmid
You can make use of it. (6) Next, transformant
(E. coli) I said that it would be heated or irradiated with ultraviolet rays.
Lysis of lambda futage that had been lysogenized by inducing eel
By shifting to the cycle
Recombinant recombinant DNA by in vivo packaging
It can be transformed into transduced phage particles. This transduction
-One cos and Ap in the particle r, Ori, outside
Recombinant DNA consisting of native DNA is encapsulated. This
Gene van of genomic DNA (foreign DNA)
Can be produced as a transduction fare particle
It

【0018】また、本発明者らは哺乳動物細胞に対する
選択マーカーを持つていて、哺乳動物細胞への遺伝子移
入を目的とするコスミドベクター、pTcosApr
ori/TK/cmr /neor (図3)を作成した。
pTcosApr /ori/TK/cmr /neo
r は、pRH(−44)もしくはpLH(+129)由
来の同一方向性のあるcos3個と、Tn903由来の
neor 、pNT−31由来のcmr 、pBR−327
由来のApr とori及びpTK−4由来のTK遺伝子
〔イシウラ エムら、モレキユラー セルラー バイオ
ロジー、Ishiura,M.,et al.,Mo
l.Cell.Biol.,,607(1982)〕
とからなる。
Further, the present inventors have having a selection marker for mammalian cells, cosmid vectors for the purpose of gene transfer into mammalian cells, pTcosAp r /
ori / TK / cm r / neo r ( Figure 3) was created.
pTcosAp r / ori / TK / cm r / neo
r is three cos having the same directionality derived from pRH (−44) or pLH (+129), neo r derived from Tn903, cm r derived from pNT-31, and pBR-327.
Derived from Ap r and ori and TK gene derived from pTK-4 [Ishiura Em et al., Molecular Cellular Biology, Ishiura, M. et al. , Et al. , Mo
l. Cell. Biol. , 2 , 607 (1982)]
Consists of.

【0019】このコスミドベクターは、前記したpTc
osApr /ori/cmr /neor と同様に、ゲノ
ムDNA遺伝子バンクを製造できる。すなわち、同一の
方向性を持つた3個のcosがあり、ClaIとBam
HIで切断することにより、それぞれcosを1個もし
くは2個持つた右腕と左腕とが等モルでき、BamHI
サイトに35〜45Kbpの大きさのゲノムDNAを挿
入させた組換え体DNAを作成できる。そして、この組
換え体DNAは、in vitroパツケージングによ
つて形質導入フアージ粒子に変換し、大腸菌(ラムダフ
アージが溶原化している)に移すことができ、組換え体
DNAを含む大腸菌は、アンピシリンもしくはクロラム
フエニコールで選択することによつて得ることができ
る。
This cosmid vector has the above-mentioned pTc.
Like the osAp r / ori / cm r / neo r, it can be produced of genomic DNA gene bank. That is, there are 3 cos with the same direction, and ClaI and Bam
By cutting with HI, the right arm and the left arm each having one or two cos can be equimolar, and BamHI
Recombinant DNA can be prepared by inserting genomic DNA having a size of 35 to 45 Kbp into the site. Then, this recombinant DNA can be converted into transduced phage particles by in vitro packaging and transferred to Escherichia coli (lambda lysogen is lysogenized). Alternatively, it can be obtained by selecting with chloramphenicol.

【0020】次に、トラスホーマント(大腸菌)に誘発
をかけて、2個のcosを持つた組換え体DNAをin
vivoパツケージングで形質導入フアージ粒子に変
換して、遺伝子バンクを製造できる。さらに、この形質
導入フアージ粒子は、TK遺伝子を持つので、哺乳動物
の培養細胞へ遺伝子移入した際に、チミジンキナーゼ
(TK)活性をマーカーとすることによつて、ベクター
由来の組換え体DNAの移入の判定が培養細胞レベルで
可能であるという利点がある。
Next, a recombinant DNA having two coss was induced by inducing a trasformant (Escherichia coli).
Gene banks can be produced by conversion into transduced phagy particles by vivo packaging. Furthermore, since this transduction phage particle has a TK gene, it can be used as a marker for thymidine kinase (TK) activity when the gene is transferred into cultured mammalian cells so that the recombinant DNA derived from the vector can be obtained. There is an advantage that transfer determination can be performed at the level of cultured cells.

【0021】本発明は、かかる新規コスミドベクターを
用いる遺伝子バンクの製造法に関するものであるが、本
発明に用いられるcosとしては、ラムダフアージまた
はラムドイドフアージ由来のものが挙げられる。特に、
ラムダフアージ由来のcosが好ましいものとして挙げ
られる。また、本発明のコスミドベクターで形質導入フ
アージ粒子として遺伝子バンクを製造するためには、同
一分子内に同一の方向性を持つたcos3個ベクター中
に存在すれば充分であるが、3個以上cosがベクター
中にあつてもかまわない。
[0021] The present invention relates to a method for producing a gene bank using such a novel cosmid vector. Examples of cos used in the present invention include those derived from lambda or lambda. In particular,
The cos derived from lambda fragrance is mentioned as a preferable thing. Further, in order to produce a gene bank as a transduction phage particle with the cosmid vector of the present invention, it is sufficient if it exists in three cos vectors having the same orientation in the same molecule, but three or more cos. May be included in the vector.

【0022】本発明のベクターは、2種類の制限酵素で
切ることによつて、それぞれcosを少なくとも1個も
しくは2個持つた右腕と左腕ができるのであるが、この
2種類の制限酵素の組合せとしては、PvuIIとBam
HI、PvuIIとBg1II、ClaIとBamHI、C
laIとBglIIなどを挙げることができる。勿論、こ
の他にも組合せは考えることができるので、これらに限
定されるものではない。本発明のベクター中には、ベク
ター由来のDNA断片が挿入されたことを、判定するた
めには一般的に薬剤耐性による選択が行われる。従っ
て、本発明のベクター中にも薬剤耐性を発現するDNA
断片が組込まれていることが好ましい。
The vector of the present invention has a right arm and a left arm each having at least one cos or two by cutting with two kinds of restriction enzymes. As a combination of these two kinds of restriction enzymes, Is PvuII and Bam
HI, PvuII and Bg1II, ClaI and BamHI, C
laI and BglII can be mentioned. Of course, other combinations can be considered, and the combination is not limited to these. In order to determine that the vector-derived DNA fragment has been inserted into the vector of the present invention, selection by drug resistance is generally performed. Therefore, DNA expressing drug resistance in the vector of the present invention
It is preferred that the fragment is integrated.

【0023】薬剤耐性としては、アンピシリン耐性、テ
トラサイクリン耐性、ネオマイシン(カナマイシン)耐
性、もしくはクロラムフエニコール耐性など通常の抗生
物質耐性が挙げられる。pTcosApr /ori/c
r /neor 及び、pTcosApr /ori/TK
/cmr /neor はアンピシリン耐性遺伝子、クロラ
ムフエニコール耐性遺伝子及びネオマイシン耐性遺伝子
を有している。本発明のベクターを用いてゲノムDNA
(外来DNA)の遺伝子バンクを製造し、哺乳動物の培
養細胞へ遺伝子(遺伝子バンク)移入する際には、ベク
ター由来のDNA断片が挿入されたことを判定するため
に特定の生理機能を発現するDNA断片が本発明のベク
ター中に組込まれているのが好ましい。
Examples of drug resistance include usual antibiotic resistance such as ampicillin resistance, tetracycline resistance, neomycin (kanamycin) resistance, or chloramphenicol resistance. pTcosAp r / ori / c
m r / neo r and, pTcosAp r / ori / TK
/ Cm r / ne o r has an ampicillin resistance gene, a chloramphenicol resistance gene and a neomycin resistance gene. Genomic DNA using the vector of the present invention
When a gene bank of (foreign DNA) is produced and transferred to a cultured cell of a mammal (gene bank), a specific physiological function is expressed in order to determine that a vector-derived DNA fragment has been inserted. It is preferred that the DNA fragment is integrated in the vector of the present invention.

【0024】特定の生理機能を発現せしめる遺伝子とし
ては、アミノグリコシド3’−ホスホトランスフエラー
ゼ(neo)遺伝子〔オカ、スギサキ アンド タカナ
ミ、ジヤナール モレキユラー バイオロジー(Ok
a,Sugisaki & Takanami,J.M
ol.Biol.),147,217(1981)〕、
チミジンキナーゼ(TK)遺伝子〔ウイグラー、エム
等、セル(Wigler,M.et al.,Cel
l),14,725(1978)、アデニンホスホリボ
シルトランスフエラーゼ(APRT)遺伝子〔ウイグラ
ー、エム等、プロシーデイングス オブ ナシヨナル
アカデミ オブ サイエンシズ ユー・エス・エー(W
igler,M.,et al.,Pro.Natl.
Acad.Sci.U.S.A.),76,1373
(1979)〕、ヒポキサンチングアニンホスホリボシ
ルトランンスフエラーゼ(HGPRT)遺伝子〔グラ
フ、エル・エイチ・ジユニア等、ソマテイツク セルラ
ー ジエネテイクス(Graf,L.H.Jr.,et
al.,Somat.Cell.Genet.),
,1031(1979)〕、キサンチングアニンホス
ホリボシトランスフエラーゼ(XGPRT又はgpt)
遺伝子〔ベルグ、ピー等、モレキユラー セルラー バ
イオロジー(Berg,P.,et al.,Mol.
Cell.Biol.),,449(1981)〕な
どが挙げられる。本発明の新規コスミドベクターpTc
osApr /ori/TK/cmr /neor はTK遺
伝子を有している。
Genes expressing a specific physiological function include aminoglycoside 3'-phosphotransferase (neo) gene [Oka, Sugisaki and Takanami, Jianal Morekiurer Biology (Ok
a, Sugisaki & Takanami, J .; M
ol. Biol. ), 147 , 217 (1981)],
Thymidine kinase (TK) gene [Wiggler, M. et al., Cell (Wigler, M. et al., Cel
l), 14 , 725 (1978), adenine phosphoribosyl transferase (APRT) gene [Wiggler, M et al., Proceedings of National
Academia of Sciences USA (W
igler, M .; , Et al. , Pro. Natl.
Acad. Sci. U. S. A. ), 76 , 1373
(1979)], hypoxanthine guanine phosphoribosyl trantransferase (HGPRT) gene [Graph, L.H.
al. , Somat. Cell. Genet. ),
5 , 1031 (1979)], xanthine guanine phosphoribosyl transferase (XGPRT or gpt).
Gene [Berg, P., et al., Molecular Cellular Biology (Berg, P., et al., Mol.
Cell. Biol. ), 1 , 449 (1981)] and the like. The novel cosmid vector pTc of the present invention
osAp r / ori / TK / cm r / neo r has the TK gene.

【0025】さらに、本発明のベクター中には、Col
EI由来の複製機能を有する遺伝子画分を有することが
好ましい。本発明において用いられる外来DNAの例と
しては、細菌、糸状菌、酵母などの微生物、高等動植物
もしくは各種フアージ等に由来するDNAが挙げられ
る。また、本発明において用いられる制限酵素(DNA
断片の特定の塩基配列部位を選択的に切断する機能を有
する酵素)や制限酵素により切断されて生じるDNA接
着末端と、これと相補的な関係のある他のDNA断片接
着末端を結合させるために用いる酵素(リガーゼ)、あ
るいは互いに相補的でないDNA末端同志を結合させる
ためにDNA末端同志を互いに相補的な接着末端にする
酵素、あるいはこれらを結合させるリガーゼについては
すでに良く知られ、数多くの酵素が市販され、それらを
用いる手法等についても広く開示されている〔モレキユ
ラー クローニング コールド スプリング ハーバー
ラボラトリー、マニアテイス、テイ等(Molecu
lar Cloning,Cold Spring H
arbor Laboratory,Maniati
s,T.,et al.),(1982)〕ので、それ
らを利用すればよい。
Furthermore, in the vector of the present invention, Col
It is preferable to have a gene fraction having a replication function derived from EI. Examples of the foreign DNA used in the present invention include DNA derived from microorganisms such as bacteria, filamentous fungi, yeasts, higher animals and plants, various types of phages, and the like. In addition, the restriction enzyme (DNA
In order to join a DNA cohesive end generated by cleavage with an enzyme having the function of selectively cleaving a specific nucleotide sequence site of a fragment) or a restriction enzyme and another DNA fragment cohesive end having a complementary relationship therewith The enzyme to be used (ligase), the enzyme that makes DNA terminal ends that are not complementary to each other to make sticky ends complementary to each other, or the ligase that connects them is already well known, and many enzymes are known. It is commercially available and the methods using them are widely disclosed [Molecuyler Cloning Cold Spring Harbor Laboratory, Maniathes, Tay, etc. (Molecu
lar Cloning, Cold Spring H
arbor Laboratory, Maniati
S.T. , Et al. ), (1982)], they may be used.

【0026】本発明のベクターを用い、ゲノムDNA
(外来DNA)の遺伝子バンクを作成することによつ
て、有用物質を発現せしめる特定の遺伝子を効率よく見
出すことが可能である。この特定の遺伝子とは、細菌、
糸状菌、酵母などの微生物、高等動植物あるいは各種フ
アージ等に由来するDNAがあり、具体的な有用物質と
しては、例えば各種ホルモン、酵素、さらには抗生物質
やアミノ酸などの合成系酵素等が挙げられる。
Genomic DNA using the vector of the present invention
By creating a gene bank of (foreign DNA), it is possible to efficiently find a specific gene that expresses a useful substance. This particular gene is a bacterium,
There are DNAs derived from microorganisms such as filamentous fungi and yeasts, higher animals and plants, and various types of phages. Specific useful substances include, for example, various hormones, enzymes, and synthetic enzymes such as antibiotics and amino acids. .

【0027】以下、実施例を挙げて本発明をいっそう詳
細に説明する。 実施例1 pTcosApr /ori/cmr /neo
r の作成及び調製(図4、図5及び図6) (a)pHScosの作成及び調製 (1)作成 コスミドベクターであるpRH(−44)10μgを、
反応混液100μl〔150mMNaCl、6mMTr
is−HCl(pH7.9)、6mMMgCl2 、10
0μg/mlBSA〕で、69ユニツトの制限酵素Ba
mHI(New England Biolabs社
製)と2時間反応させて完全に消化した。反応終了後、
等量の水飽和フエノールで抽出を行い、水層をセカンダ
リブタノールで濃縮後、0.1倍容量の3M酢酸ナトリ
ウムと2倍容量のエタノールを加えて、DNAを沈澱と
して得、95%エタノールで洗つたのち、水流ポンプで
乾燥を行い、沈澱を10mMTris−HCl(pH
8.0)、0.1mMEDTAからなる水溶液(以下、
10t/0.1Eと略す)7μl (〜1μg/μl )に
溶解させた。
Hereinafter, the present invention will be described in more detail with reference to examples. Example 1 pTcosAp r / ori / cm r / neo
Preparation and preparation of r (FIGS. 4, 5 and 6) (a) Preparation and preparation of pHScos (1) Preparation 10 μg of pRH (−44), which is a cosmid vector,
Reaction mixture 100 μl [150 mM NaCl, 6 mM Tr
is-HCl (pH 7.9), 6 mM MgCl 2 , 10
0 μg / ml BSA], 69 units of restriction enzyme Ba
It was completely digested by reacting with mHI (New England Biolabs) for 2 hours. After the reaction,
Extract with an equal volume of water-saturated phenol, concentrate the aqueous layer with secondary butanol, add 0.1 volumes of 3M sodium acetate and 2 volumes of ethanol to obtain DNA as a precipitate, and wash with 95% ethanol. After that, it was dried with a water-jet pump, and the precipitate was washed with 10 mM Tris-HCl (pH
8.0), an aqueous solution of 0.1 mM EDTA (hereinafter,
It was dissolved in 7 μl (abbreviated as 10 t / 0.1E) (˜1 μg / μl).

【0028】次に、このBamHIで消化したDNA溶
液1μl (〜1μg)を反応混液25μl 〔50mMT
ris−HCl(pH7.2)、10mMMgSO4
0.1mMDTT、50μg/mlBSA、80μMd
ATP、80μMdCTP、80μMdGTP、80μ
MdTTP〕で、2ユニツトのKlenow酵素(Bo
ehringer Mannheim社製)と22℃で
30分間反応させて、互いに相補鎖が存在する2本鎖D
NA断片(cohesive end)を、両端がそろ
つた2本鎖DNA断片(blunt end)に変え
た。反応終了後、反応液を65℃で10分間熱処理して
Klenow酵素を失活させた。
Next, 1 μl (to 1 μg) of this BamHI-digested DNA solution was added to 25 μl of the reaction mixture [50 mMT.
ris-HCl (pH 7.2), 10 mM MgSO 4 ,
0.1 mM DTT, 50 μg / ml BSA, 80 μMd
ATP, 80μMdCTP, 80μMdGTP, 80μ
MdTTP] with 2 units of Klenow enzyme (Bo
Ehringer Mannheim) at 30 ° C. for 30 minutes, and a double-stranded chain D having complementary strands to each other.
The NA fragment (cohesive end) was changed to a double-stranded DNA fragment (blunt end) having both ends aligned. After completion of the reaction, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme.

【0029】次に、このDNA溶液10μl (0.4μ
g)と、SalIリンカー〔d(pG−G−T−C−G
−A−C−C)〕2μgとを、反応混液20μl 〔50
mMTris−HCl(pH7.4)10mMMgCl
2 、10mMDTT、1mMスペルミジン、1mMAT
P、100μg/mlBSA〕で6ユニツトのT4−D
NAリガーゼと22℃で6時間反応させて連結した。そ
の後、フエノール抽出を行い、DNAをエタノール沈澱
として得た。
Next, 10 μl of this DNA solution (0.4 μl
g) and SalI linker [d (pG-G-T-C-G
-A-C-C)] 2 μg and 20 μl of the reaction mixture [50
mMTris-HCl (pH 7.4) 10 mM MgCl
2 , 10 mM DTT, 1 mM spermidine, 1 mMAT
P, 100 μg / ml BSA] 6 units T4-D
Ligation was performed by reacting with NA ligase at 22 ° C. for 6 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.

【0030】このDNA沈澱を、反応混液600μl
〔150mMNaCl、6mMTris−HCl(pH
7.9)、6mMMgCl2 、6mMDTT、100μ
g/mlBSA〕で1000ユニツトの制限酵素Sa1
I(Takara社製)と37℃で4時間反応させて消
化した後、0.8%調製用アガロースゲルにかけて、1
0mAで12時間電気泳動した。分解されたDNA断片
は臭化エチジウム染色と長波長紫外線照明によつて見え
てくる。cos及びori、ApからなるDNA断片
(3.89Kbp)を含有するゲルを切り出したのち、
5倍容量の抽出液〔0.5MNH4 OAc、1mMED
TA(pH7.5):水飽和フエノール=1:1〕の存
在下で、ゲルをすりつぶしてDNAを溶出させた。
This DNA precipitate was mixed with 600 μl of the reaction mixture.
[150 mM NaCl, 6 mM Tris-HCl (pH
7.9), 6 mM MgCl 2 , 6 mM DTT, 100 μ
g / ml BSA] 1000 units of restriction enzyme Sa1
I (Takara) was allowed to react at 37 ° C. for 4 hours for digestion and then applied to 0.8% preparative agarose gel for 1
Electrophoresis was carried out at 0 mA for 12 hours. The decomposed DNA fragment becomes visible by ethidium bromide staining and long-wavelength ultraviolet illumination. After cutting out a gel containing a DNA fragment (3.89 Kbp) consisting of cos, ori, and Ap,
5 times the volume of extract [0.5M NH 4 OAc, 1 mM ED
In the presence of TA (pH 7.5): water-saturated phenol = 1: 1], the gel was ground to elute the DNA.

【0031】そして、溶出液をセカンダリーブタノール
で濃縮後、0.1倍容量の3M酢酸ナトリウムと2倍容
量のエタノールを加えてDNA沈澱として得た。このD
NA沈澱を反応混液20μl 〔50mMTris−HC
l(pH7.4)、10mMMgCl2 、10mMDT
T、1mMスペルミジン、1mMATP、100μg/
mlBSA〕で、6ユニツトのT4−DNAリガーゼと
12℃で17.5時間反応させ、cosおよびori、
Apr からなるDNA断片(3.89Kbp)を閉環化
させた。その後、フエノール抽出を行い、DNAをエタ
ノール沈澱として得、沈澱を0.1MTris−HCl
(pH7.5)溶液20μl に溶解させた。
The eluate was concentrated with secondary butanol, and 0.1 times volume of 3M sodium acetate and 2 times volume of ethanol were added to obtain a DNA precipitate. This D
NA precipitation was reacted with 20 μl of reaction mixture [50 mM Tris-HC
1 (pH 7.4), 10 mM MgCl 2 , 10 mM DT
T, 1 mM spermidine, 1 mM ATP, 100 μg /
mlBSA], and reacted with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours to prepare cos and ori,
The DNA fragment consisting of Ap r (3.89 Kbp) was cyclized. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1 M Tris-HCl.
It was dissolved in 20 μl of (pH 7.5) solution.

【0032】(2)トランスホーメーシヨン このDNA溶液10μl を大腸菌HB101のcomp
etent cell100μl (対数増殖期の大腸菌
HB101を0〜4℃で0.1MCaCl2 溶液で15
分間処理後、もとの培養液の1/10容量の0.1MC
aCl2 /14%グリセロール溶液に再懸濁し、−70
℃に保存)とよく混合し、0℃で10分間、続いて37
℃で5分間保温して、DNAを大腸菌内に取込ませた
後、これにL−ブロス(1%Bactotrypton
e、0.5%酵母エキス、0.5%NaCl、0.1%
グルコース)2mlを加えて、37℃で1時間振とう培
養した。この菌体懸濁液を20μg/mlのアンピシリ
ンを含むL−プレート(L−プロースに寒天を1%添加
したプレート)上にまき、37℃で24〜48時間培養
し、アンピシリン耐性のクローンを得た。
(2) Transformation 10 μl of this DNA solution was added to E. coli HB101 comp.
100 μl of ent cell (E. coli HB101 in logarithmic growth phase at 0-4 ° C. in 0.1 M CaCl 2 solution
After treatment for 1 minute, 0.1MC of 1/10 volume of the original culture solution
resuspended in NaCl 2/14% glycerol solution, -70
Mix well) and store at 0 ° C for 10 minutes, then 37
After incubating at 0 ° C. for 5 minutes to incorporate DNA into E. coli, L-broth (1% Bactotrypton was added thereto).
e, 0.5% yeast extract, 0.5% NaCl, 0.1%
(Glucose) (2 ml) was added, and the mixture was shake-cultured at 37 ° C. for 1 hour. The cell suspension was spread on an L-plate (a plate containing 1% agar added to L-prose) containing 20 μg / ml of ampicillin, and cultured at 37 ° C. for 24 to 48 hours to obtain ampicillin-resistant clones. It was

【0033】3)少量培養、及び少量DNA調製 Apr であるクローンをL−ブロス2ml中(Ap20
μg/ml含有)で37℃、一晩振とうして、増殖させ
た。培養液1.5mlをエツペンドルフチユーブにと
り、机上遠心分離機にかけて集菌後、この菌体を抽出液
〔8%シヨ糖、0.5%Triton X−100、5
0mMEDTA(pH8.0)、10mMTris−H
Cl(pH8.0)〕0.35mlに再懸濁させた。次
に、リゾチーム溶液25μl 〔10mg/ml、10m
MTris−HCl(pH8.0)〕を加え混合したの
ち、チユーブを沸騰水中に40秒間おいた。そして、直
ちにチユーブを4℃にて遠心分離機(21,000rp
m、15分間)にかけて上澄液を得、これにRNase
A溶液(20mg/ml、10t/0.1E)0.5μ
l を加えて37℃で1時間保温してRNAを分解させ
た。その後、フエノール抽出で除蛋白後、DNAをエタ
ノール沈澱として得、沈澱を10t/0.1E20μl
に溶解させて、プラスミドDNA溶液を得た。
3) Small amount culture and small amount DNA preparation Ap r clone was cloned in 2 ml of L-broth (Ap20).
The cells were allowed to grow by shaking overnight at 37 ° C. (containing μg / ml). 1.5 ml of the culture solution was placed in an Eppendorf tube, and the cells were collected by a desk centrifuge, and the cells were extracted with an extract [8% sucrose, 0.5% Triton X-100, 5
0 mM EDTA (pH 8.0), 10 mM Tris-H
Cl (pH 8.0)] 0.35 ml. Next, 25 μl of lysozyme solution [10 mg / ml, 10 m
MTris-HCl (pH 8.0)] was added and mixed, and then the tube was placed in boiling water for 40 seconds. Then, immediately put the tube in a centrifuge (21,000 rp at 4 ° C).
m, 15 minutes) to obtain a supernatant liquid, which was RNase
Solution A (20mg / ml, 10t / 0.1E) 0.5μ
l was added and the mixture was kept warm at 37 ° C. for 1 hour to decompose RNA. Then, after deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was mixed with 10 t / 0.1E20 μl.
To obtain a plasmid DNA solution.

【0034】(4)プラスミドDNAの特性化 そして、このプラスミドDNA溶液1μl 又は2μl を
制限酵素HindIII、SalI、PvuII、PstI
などで消化したのち、0.4〜1.5%アガロースゲル
電気泳動〔40mMTris、20mM酢酸ナトリウ
ム、2mMEDTA(pH8.15);10mA、12
〜24時間〕にかけた。分解されたDNA断片は臭化エ
チジウム染色と長波長紫外線照射によつて検出できる。
このようにして、プラスミドDNAの制限地図を作成す
ることによつて、各クローンが持つているプラスミドD
NAを特性化した。そして、pRH(−44)のBam
HIサイトとSalIサイトの間のDNA断片(0.3
1Kbp)を欠き、その場所にSalIリンカーが挿入
されたプラスミド:pHScos(図4)を持つ大腸菌
を得た。
(4) Characterization of plasmid DNA Then, 1 μl or 2 μl of this plasmid DNA solution was added to the restriction enzymes HindIII, SalI, PvuII and PstI.
After digestion with, etc., 0.4-1.5% agarose gel electrophoresis [40 mM Tris, 20 mM sodium acetate, 2 mM EDTA (pH 8.15); 10 mA, 12
~ 24 hours]. The decomposed DNA fragment can be detected by ethidium bromide staining and long-wavelength ultraviolet irradiation.
In this way, by constructing a restriction map of plasmid DNA, the plasmid D possessed by each clone can be obtained.
The NA was characterized. And Bam of pRH (-44)
DNA fragment between the HI site and the SalI site (0.3
1 Kbp) was deleted, and Escherichia coli harboring a plasmid: pHScos (FIG. 4) in which a SalI linker was inserted at that position was obtained.

【0035】(5)大量培養、及びプラスミドDNAの
調製 この大腸菌を、TYG−P培地(1%Bactotry
ptone、0.1%酵母エキス、0.2%グルコー
ス、0.1%NH4 Cl、0.3%NaCl、0.01
%Na2 SO4 、0.08%MgCl2 ・6H2 O、
1.52%Na2 HPO4 ・12H2 O、0.3%KH
2 PO4 )1l 中(Ap20μg/ml含有)で、37
℃で振とう培養し、600nmでの吸光度(A600 )が
1.0になつた時点で、クロラムフエニコールを100
μg/mlの濃度になるように添加し、さらに15時間
37℃で振とう培養した。培養終了後、遠心分離機
(6,000rpm、10分間)にかけて集菌を行い、
次に菌体を25%シヨ糖、50mMTris−HCl
(pH8.0)からなる等張緩衝液18mlに再懸濁液
した。これに、リゾチーム溶液〔5mg/ml、0.2
5MTris−HCl(pH8.0)〕3.6mlを加
え、おだやかに混合し、0℃で5分間おいたのち、0.
25MEDTA(pH8.0)溶液7.2mlを加え、
おだやかに混合し、0℃で5分間おいた。
(5) Large-scale culture and preparation of plasmid DNA This E. coli was cultured in TYG-P medium (1% Bactortry).
ptone, 0.1% yeast extract, 0.2% glucose, 0.1% NH 4 Cl, 0.3% NaCl, 0.01
% Na 2 SO 4 , 0.08% MgCl 2 .6H 2 O,
1.52% Na 2 HPO 4 · 12H 2 O, 0.3% KH
2 PO 4 ) in 1 l (containing 20 μg / ml of Ap), 37
After culturing with shaking at 0 ° C., when the absorbance at 600 nm (A 600 ) reached 1.0, 100 ml of chloramphenicol was added.
The mixture was added to give a concentration of μg / ml, and the mixture was further cultured by shaking at 37 ° C. for 15 hours. After culturing, the cells were collected by centrifugation (6,000 rpm, 10 minutes),
Next, the cells were treated with 25% sucrose and 50 mM Tris-HCl.
It was resuspended in 18 ml of isotonic buffer consisting of (pH 8.0). To this, a lysozyme solution [5 mg / ml, 0.2
3.6 ml of 5M Tris-HCl (pH 8.0)] was added and gently mixed, and the mixture was kept at 0 ° C. for 5 minutes.
Add 7.2 ml of 25 MEDTA (pH 8.0) solution,
Mix gently and place at 0 ° C. for 5 minutes.

【0036】その後、10%SDS溶液2.7mlと5
MNaCl溶液8.1mlとを加えおだやかに混合し、
0℃で一晩おいた後、遠心分離機(20,000rp
m、45分間)にかけて粗溶菌液(cleared l
ysate)〜39mlを得た。この粗溶菌液に、RN
aseA溶液(20mg/ml、10t/0.1E)2
0μl を加えて、37℃にて1時間保温してRNAを分
解させたのち、フエノール抽出で除蛋白を行い、さらに
セフアロース2Bのゲル濾過にかけた。プラスミドDN
Aを含むボイドクラクシヨンから、DNAをエタノール
沈澱として得、次にDNAを塩化セシウム−臭化エチジ
ウム溶液〔1MTris−HCl(pH8.0)0.3
75ml、0.25MEDTA(pH8.0)0.30
ml、H2O6.45ml、CsCl 17.5g、Et
Br溶液(4mg/ml)0.375ml〕で平衡密度
勾配遠心(60,000rpm、12時間)にかけた。
Then, 2.7 ml of 10% SDS solution and 5
Add 8.1 ml of MNaCl solution and mix gently,
After overnight at 0 ° C, centrifuge (20,000 rp
m, 45 minutes) over a crude lysate (cleared l)
Ysate) -39 ml was obtained. RN is added to this crude lysate
aseA solution (20mg / ml, 10t / 0.1E) 2
After adding 0 μl and incubating at 37 ° C. for 1 hour to decompose RNA, deproteinization was carried out by phenol extraction, and then Sepharose 2B was subjected to gel filtration. Plasmid DN
DNA was obtained as an ethanol precipitate from a void claxion containing A, and then the DNA was cesium chloride-ethidium bromide solution [1M Tris-HCl (pH 8.0) 0.3.
75 ml, 0.25 MEDTA (pH 8.0) 0.30
ml, H 2 O 6.45 ml, CsCl 17.5 g, Et
The solution was subjected to equilibrium density gradient centrifugation (60,000 rpm, 12 hours) with Br solution (4 mg / ml, 0.375 ml).

【0037】そうすると、共有結合で閉鎖された環状の
プラスミドDNA(ccc−DNA)は、遠沈管中で長
波長紫外線照射下において、線状のプラスミドDNA及
び染色体のけい光帯の下にバンド状に見えてくる。この
ccc−DNAのバンドを分画し、CsCl水溶液で飽
和したイソプロパノールで抽出を行つて、臭化エチジウ
ムを取除いた後、10t/0.1E1l に対して透析を
行つた。そして、透析内液から、ccc−DNAをエタ
ノール沈澱として得、沈澱を10t/0.1E2mlに
溶解させてpHScosのプラスミドDNA溶液を調製
した。
Then, the covalently closed circular plasmid DNA (ccc-DNA) becomes a band-like band under the fluorescent band of the linear plasmid DNA and the chromosome in the centrifuge tube under long-wavelength ultraviolet irradiation. I can see it. The ccc-DNA band was fractionated, extracted with isopropanol saturated with a CsCl aqueous solution to remove ethidium bromide, and then dialyzed against 10 t / 0.1E1 l. Then, ccc-DNA was obtained as an ethanol precipitate from the dialysate, and the precipitate was dissolved in 10 t / 0.1E2 ml to prepare a pHScos plasmid DNA solution.

【0038】(b)pHBcosの作成及び調製 pHScos10μgを反応混液400μl で、185
ユニツトのSalIと37℃で2時間反応させて消化し
た。そして、フエノール抽出で除蛋白後、DNAをエタ
ノール沈澱として得、沈澱を10t/0.1E7μl
(〜1μg/μl)に溶解させた。次に、このSalI
で消化したDNA溶液1μl (〜1μg)を反応混液2
5μl で、2ユニツトのKlenow酵素と22℃で3
0分間反応させて、cohesive endをblu
nt endに変えた。そして、反応液を65℃で10
分間熱処理してKlenow酵素を失活させた。
(B) Preparation and Preparation of pHBcos 10 μg of pHScos was added to 400 μl of the reaction mixture to prepare 185
It was digested by reacting with SalI of unit at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1E7 μl.
(˜1 μg / μl). Next, this SalI
1 μl (~ 1 μg) of DNA solution digested with
5 μl with 2 units of Klenow enzyme and 3 at 22 ° C
After reacting for 0 minutes, cohesive end is blue
changed to nt end. Then, the reaction solution is heated at 65 ° C. for 10 minutes.
The Klenow enzyme was inactivated by heat treatment for minutes.

【0039】このDNA溶液10μl (0.4μg)
と、BamHIリンカー〔d(pC−G−G−A−T−
C−C−G)〕2μgとを、反応混液20μl で6ユニ
ツトのT4−DNAリガーゼと22℃で6時間反応させ
て連結した。そして、この反応液10μl を反応混液5
0μl で15ユニツトのT4−DNAリガーゼと12℃
で17.5時間反応させて閉環化した。その後、フエノ
ール抽出を行い、DNAをエタノール沈澱として得、沈
澱を0.1MTris−HCl(pH7.5)溶液20
μl に溶解させた。
10 μl (0.4 μg) of this DNA solution
And a BamHI linker [d (pC-G-G-A-T-
C-C-G)] 2 μg were ligated by reacting with 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 22 ° C. for 6 hours. Then, 10 μl of this reaction solution is added to the reaction mixture 5
0 unit of 15 unit T4-DNA ligase and 12 ℃
And reacted for 17.5 hours for ring closure. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 20
It was dissolved in μl.

【0040】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r クローンを得た。そして、これらのクローンのもつ
プラスミドDNAの特性を調べて、pHScosのSa
lIサイトのBamHIリンカーを挿入させたプラスミ
ド(この場合、BamHIサイトの両側にSalIサイ
トが再構成される):pHBcos(図4)を持つ大腸
菌を得た。この大腸菌を、TYG−P培地1l 中で増殖
させたのち、菌体よりccc−DNAを分離精製してp
HBcosのプラスミドDNAを調製した。
Next, E. coli (HB101) was transformed with 10 μl of this DNA solution, and then A
A p r clone was obtained. Then, the characteristics of the plasmid DNA possessed by these clones were investigated, and Sa of pHScos was examined.
A plasmid having a BamHI linker inserted at the 11 site (in this case, SalI sites are reconstructed on both sides of the BamHI site): Escherichia coli having pHBcos (FIG. 4) was obtained. After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells and p.
HBcos plasmid DNA was prepared.

【0041】(c)pCHcosの作成及び調製 コスミドベクターであるpLH(+129)10μgを
反応混液100μl 〔50mMNaCl、100mMT
ris−HCl(pH7.5)、5mMMgCl2 、1
00μg/mlBSA〕で、69ユニツトの制限酵素E
coRI(Takara社製)と37℃で2時間反応さ
せて消化した。そして、フエノール抽出で除蛋白後、D
NAをエタノール沈澱として得、沈澱10t/0.1E
7μl (〜1μg/ml)に溶解させた。次に、Eco
RIで消化したDNA溶液1μl(〜1μg)を、反応
混液25μl で、2ユニツトのKlenow酵素と22
℃で30分間反応させて、cohesive endを
blunt endに変えた。そして、反応液を65℃
で10分間熱処理してKlenow酵素を失活させた。
次に、このDNA溶液10μl (0.4μg)と、Cl
aIリンカー〔d(pC−A−T−C−G−A−T−
G)〕2μgとを、反応混液20μl で、6ユニツトの
T4−DNAリガーゼと22℃で6時間反応させて連結
した。
(C) Preparation and preparation of pCHcos 10 μg of cosmid vector pLH (+129) was mixed with 100 μl of reaction mixture [50 mM NaCl, 100 mMT
ris-HCl (pH 7.5), 5 mM MgCl 2 , 1
00 μg / ml BSA], 69 units of restriction enzyme E
It was digested by reacting with coRI (Takara) at 37 ° C for 2 hours. After deproteinization with phenol extraction, D
NA was obtained as an ethanol precipitate, which was precipitated 10t / 0.1E
It was dissolved in 7 μl (˜1 μg / ml). Next, Eco
1 μl (~ 1 μg) of the DNA solution digested with RI was added to 2 units of Klenow enzyme and 22 μl in a reaction mixture of 25 μl.
After reacting at 0 ° C. for 30 minutes, the cohesive end was changed to the blunt end. Then, the reaction solution is heated to 65 ° C.
The Klenow enzyme was inactivated by heat treatment for 10 minutes.
Next, 10 μl (0.4 μg) of this DNA solution and Cl
aI linker [d (pC-A-T-C-G-A-T-
G)] 2 μg was ligated with 20 μl of the reaction mixture by reacting with 6 units of T4-DNA ligase at 22 ° C. for 6 hours.

【0042】そして、この反応液10μl を、反応混液
50μl で15ユニツトのT4−DNAリガーゼと12
℃で17.5時間反応させて閉環化した。その後、フエ
ノール抽出を行い、DNAをエタノール沈澱として得、
沈澱を0.1MTris−HCl(pH7.5)溶液2
0μl に溶解させた。次に、このDNA溶液10μlで
大腸菌(HB101)をトランスホーメーションした
後、Apr クローンを得た。そして、これらのクローン
のもつプラスミドDNAの特性を調べて、pLH(+1
29)のEcoRIサイトにClaIリンカーを挿入さ
せたプラスミド(この場合、ClaIサイトの両側にE
coRIサイトが再構成される。):pCHcos(図
4)を持つ大腸菌を得た。この大腸菌を、TYG−P培
地1l 中で増殖させたのち、菌体よりccc−DNAを
分離精製してpCHcosのプラスミドDNAを調製し
た。
Then, 10 μl of this reaction solution was mixed with 50 μl of the reaction mixture and 15 units of T4-DNA ligase and 12
The ring was closed by reacting at 17.5 hours for 1 hour. Then, phenol extraction was performed to obtain DNA as ethanol precipitate,
The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 2
It was dissolved in 0 μl. Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pLH (+1
29) A plasmid having a ClaI linker inserted at the EcoRI site (in this case, E on both sides of the ClaI site).
The coRI site is reconstructed. ): E. coli with pCHcos (FIG. 4) was obtained. This Escherichia coli was grown in 1 liter of TYG-P medium, and ccc-DNA was separated and purified from the cells to prepare pCHcos plasmid DNA.

【0043】(d)pCH/HBcos(pDcos)
の作成及び調製 pCHcos20μgを、反応混液200μl 〔60m
MNaCl、7mMTris−HCl(pH7.4)、
7mMMgCl2 、6mMDTT、100μg/mlB
SA)〕で、114ユニツトの制限酵素HindIII
(New England Biolabs社製)及び
192ユニツトのPvuII(Takara社製)と37
℃で2時間反応させて消化したのち、0.8%調製用ア
ガロースゲル電気泳動にかけて、cos及びApr 、o
riを含むDNA断片(2.5Kbp)を分離精製し
て、DNAをエタノール沈澱として得、沈澱を10t/
0.1E8.5μl (〜1μg/μl )に溶解させた。
(D) pCH / HBcos (pDcos)
Preparation and Preparation of pCHcos 20 μg, Reaction Mixture 200 μl [60 m
MNaCl, 7 mM Tris-HCl (pH 7.4),
7 mM MgCl 2 , 6 mM DTT, 100 μg / ml B
SA)], a 114 unit restriction enzyme HindIII
(New England Biolabs) and 192 unit PvuII (Takara) and 37
The mixture was reacted at ℃ for 2 hours and digested, then subjected to 0.8% preparative agarose gel electrophoresis to obtain cos and Ap r , o.
A DNA fragment containing ri (2.5 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was collected at 10 t /
It was dissolved in 0.1E8.5 µl (~ 1 µg / µl).

【0044】一方、pHBcos20μgを反応混液2
00μl で、114ユニツトのHindIII 及び192
ユニツトのPvuIIと37℃で2時間反応させて消化し
たのち、0.8%調製用アガロースゲル電気泳動にかけ
て、cosを含むDNA断片(1.6Kbp)を分離精
製して、DNAをエタノール沈澱として得、沈澱を10
t/0.1E6.0μl (〜1μg/μl )に溶解させ
た。そして、pCHcosのcos及びApr 、ori
を含むHindIII /PvuII断片のDNA溶液1μl
(〜1μg)と、pHBcosのcosを含むHind
III /PvuII断片のDNA溶液1μl (〜1μg)と
を、反応混液20μl で6ユニツトのT4−DNAリガ
ーゼと12℃で17.5時間反応させて連結した。その
後、フエノール抽出を行い、DNAをエタノール沈澱と
して得、沈澱を0.1MTris−HCl(pH7.
5)溶液20μl に溶解させた。
On the other hand, 20 μg of pHBcos was added to the reaction mixture 2
At 00 μl, 114 units of HindIII and 192
After digestion with unit PvuII at 37 ° C. for 2 hours, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify the cos-containing DNA fragment (1.6 Kbp) to obtain the DNA as an ethanol precipitate. , Precipitation 10
It was dissolved in t / 0.1E 6.0 μl (˜1 μg / μl). And pCHcos cos and Ap r , ori
DNA solution of HindIII / PvuII fragment containing 1 μl
Hind containing cos of pHBcos (up to 1 μg)
1 μl (˜1 μg) of the DNA solution of III / PvuII fragment was ligated by reacting 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, which was precipitated with 0.1 M Tris-HCl (pH 7.
5) Dissolved in 20 μl of solution.

【0045】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンした後、Ap
r クローンを得た。次いで、これらのクローンのもつプ
ラスミドDNAの特性を調べて、2個のcos及びAp
r 、oriを有するプラスミド:pDcos(図4)を
持つ大腸菌を得た。この大腸菌を、TYG−P培地1l
中で増殖させたのち、菌体よりccc−DNAを分離精
製してpDcosのプラスミドDNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap
An r clone was obtained. Next, the characteristics of the plasmid DNA possessed by these clones were examined, and the two cos and Ap
A plasmid having r , ori: pDcos (FIG. 4) was obtained. This E. coli was mixed with 1 liter of TYG-P medium.
After proliferating in the medium, ccc-DNA was separated and purified from the cells to prepare pDcos plasmid DNA.

【0046】(e)pHC−79/cmr の作成および
調製 コスミドベクターであるpHC−79〔ホーン アンド
コリンズ、ジーン(Hohn & Collins,
Gene),11,291(1980)〕10μl を、
反応混液100μl〔50mMNaCl、6mMTri
s−HCl(pH7.9)、6mMMgCl2 、100
μg/mlBSA〕で、15ユニツトの制限酵素Cla
I(Boehringer Mannheim社製)と
37℃で2時間反応させて消化した。そして、フエノー
ル抽出で除蛋白後、DNAをエタノール沈澱として得、
沈澱10t/0.1E7μl (〜1μg/ml)に溶解
させた。
(E) Preparation and preparation of pHC-79 / cm r A cosmid vector pHC-79 [Horn & Collins, Gene.
Gene), 11 , 291 (1980)] 10 μl,
Reaction mixture 100 μl [50 mM NaCl, 6 mM Tri
s-HCl (pH 7.9), 6 mM MgCl 2 , 100
μg / ml BSA], 15 units of restriction enzyme Cla
I (manufactured by Boehringer Mannheim) was reacted at 37 ° C. for 2 hours for digestion. After deproteinization by phenol extraction, DNA was obtained as ethanol precipitate,
The precipitate was dissolved in 10 t / 0.1E7 μl (˜1 μg / ml).

【0047】一方、pNT−31 10μgを反応混液
200μl 〔100mMNaCl、10mMTris−
HCl(pH8.4)、6mMMgCl2 、6mMDT
T、100μg/mlBSA〕で、40ユニツトの制限
酵素TaqI(New England Biolab
s社製)と65℃で2時間反応させて消化したのち、
0.8%調製用アガロースゲル電気泳動にかけて、cm
r を含むDNA断片(0.79Kbp)を分離精製し
て、DNAをエタノール沈澱として得、沈澱を10t/
0.1E3.0μl (〜1μg/μl )に溶解させた。
そして、pHC−79をClaIで消化したDNA溶液
1μl (〜1μg)とpNT−31のcmrを含むTa
q−I断片のDNA溶液1μl (〜1μg)とを、反応
混液20μlで6ユニツトのT4−DNAリガーゼと1
2℃で17.5時間反応させて連結した。その後、フエ
ノール抽出を行い、DNAをエタノール沈澱として得、
沈澱を0.1MTris−HCl(pH7.5)溶液2
0μl に溶解させた。
On the other hand, 10 μg of pNT-31 was mixed with 200 μl of a reaction mixture [100 mM NaCl, 10 mM Tris-
HCl (pH 8.4), 6 mM MgCl 2 , 6 mM DT
T, 100 μg / ml BSA], 40 units of restriction enzyme TaqI (New England Biolab).
(manufactured by s company) at 65 ° C. for 2 hours for digestion,
Cm for 0.8% preparative agarose gel electrophoresis
A DNA fragment containing r (0.79 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was collected at 10 t /
This was dissolved in 0.1E 3.0 μl (-1 μg / μl).
Then, Ta containing 1 μl of DNA solution (˜1 μg) obtained by digesting pHC-79 with ClaI and cm r of pNT-31.
1 μl (∼1 μg) of the q-I fragment DNA solution was added to 6 units of T4-DNA ligase in 20 μl of the reaction mixture.
The reaction was carried out at 2 ° C. for 17.5 hours for ligation. Then, phenol extraction was performed to obtain DNA as ethanol precipitate,
The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 2
It was dissolved in 0 μl.

【0048】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、c
r かつApr クローンを得た。次いで、これらのクロ
ーンのもつプラスミドDNAの特性を調べて、pHC−
79のClaIサイトのcmrを挿入させたプラスミ
ド:pHC−79/cmr (図5)を持つ大腸菌を得
た。この大腸菌を、TYG−P培地1l 中で増殖させた
のち、菌体よりccc−DNAを分離精製してpHC−
79/cmr のプラスミドDNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, c
m r and Ap r clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pHC-
79 ClaI site plasmid was inserted the cm r of: pHC-79 / cm r was obtained E. coli with (Figure 5). After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells to obtain pHC-
79 / cm r of plasmid DNA was prepared.

【0049】(f)pHC−79/cmr Δ(Hind
III )の作成及び調製 pHC−79/cmr 10μgを、反応混液100μl
で35ユニツトのHindlII と37℃で2時間反応さ
せて消化した。そして、フエノール抽出で除蛋白後、D
NAをエタノール沈澱として得、沈澱を10t/0.1
E7μl (〜1μg/μl)に溶解させた。次に、この
HindIII で消化したDNA溶液1μl (〜1μg)
を、反応混液25μl で、2ユニツトのKlenow酵
素と22℃で30分間反応させて、cohesive
endをblunt endに変えた。そして、反応液
を65℃で10分間熱処理してKlenow酵素を失活
させた。次に、このDNA溶液10μl (〜0.4μ
g)を、反応混液50μl で、15ユニツトのT4−D
NAリガーゼと12℃で17.5時間反応させて閉環化
した。その後、フエノール抽出を行い、DNAをエタノ
ール沈澱として得、沈澱を0.1MTris−HCl
(pH7.5)溶液20μl に溶解させた。
(F) pHC-79 / cm r Δ (Hind
Preparation and preparation of III) 10 μg of pHC-79 / cm r was added to 100 μl of the reaction mixture.
It was digested by reacting with 35 units of Hindlll at 37 ° C for 2 hours. After deproteinization with phenol extraction, D
NA was obtained as an ethanol precipitate and the precipitate was 10 t / 0.1
It was dissolved in E7 μl (˜1 μg / μl). Next, 1 μl (~ 1 μg) of this HindIII-digested DNA solution
Was reacted with 2 units of Klenow enzyme for 30 minutes at 22 ° C. in 25 μl of the reaction mixture, and then cohesive
The end was changed to blunt end. Then, the reaction solution was heat-treated at 65 ° C. for 10 minutes to inactivate the Klenow enzyme. Next, 10 μl of this DNA solution (up to 0.4 μm)
g) in 15 μl of T4-D with 50 μl of reaction mixture
Cyclization was performed by reacting with NA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1 M Tris-HCl.
It was dissolved in 20 μl of (pH 7.5) solution.

【0050】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンした後、Ap
r かつcmr クローンを得た。そして、これらのクロー
ンのもつプラスミドDNAの特性を調べて、pHC−7
9/cmr のHindIII サイトを欠いたプラスミド:
pHC−79/cmr Δ(HindIII )(図5)を持
つ大腸菌を得た。この大腸菌を、TYG−P培地1l 中
で増殖させたのち、菌体よりccc−DNAを分離精製
して、pHC−79/cmr Δ(HindIII )のプラ
スミドDNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap
r and cm r clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pHC-7
A plasmid lacking the HindIII site at 9 / cm r :
Escherichia coli having pHC-79 / cm r Δ (HindIII) (Fig. 5) was obtained. This E. coli was grown in 1 liter of TYG-P medium, and ccc-DNA was separated and purified from the cells to prepare a plasmid DNA of pHC-79 / cm r Δ (HindIII).

【0051】(g)pUC−8/cmr の作成及び調製 pHC−79/cmr Δ(HindlII )20μgを、
反応混液200μl 〔50mM(NH4 2 SO4 、2
0mMTris−HCl(pH7.5)、10mMMg
Cl2 、100μg/mlBSA〕で、22ユニツトの
制限酵素PstI(New England Biol
abs社製)と37℃で2時間反応させて完全に消化し
た。そして、さらに反応混液500μl で、80ユニツ
トのBamHIと37℃で2時間反応させて完全に消化
したのち、0.8%調製用アガロースゲル電気泳動にか
けて、cmr を含むDNA断片(1.9Kbp)を分離
精製して、DNAをエタノール沈澱として得、沈澱を1
0t/0.1E4.0μl(〜1μg/μl )に溶解さ
せた。
(G) Preparation and Preparation of pUC-8 / cm r pHC-79 / cm r Δ (HindlII) 20 μg
Reaction mixture 200 μl [50 mM (NH 4 ) 2 SO 4 , 2
0 mM Tris-HCl (pH 7.5), 10 mM Mg
Cl 2 , 100 μg / ml BSA], 22 units of the restriction enzyme PstI (New England Biol).
Abs) and reacted at 37 ° C. for 2 hours for complete digestion. Then, the reaction mixture was further reacted with BamHI (80 units) at a temperature of 37 ° C. for 2 hours for complete digestion, and then subjected to 0.8% preparative agarose gel electrophoresis to give a DNA fragment containing cm r (1.9 Kbp). Is separated and purified to obtain DNA as an ethanol precipitate.
It was dissolved in 0t / 0.1E4.0 µl (~ 1 µg / µl).

【0052】一方、pUC−8〔ジエフエリー ヴイア
イラ アンド ジオチイム メエシング、ジーン(Je
ffery Vieira & Joachim Me
ssing,Gene),19,259(1982)〕
20μgを、反応混液200μl で、60ユニツトのP
stIと37℃で2時間反応させて完全に消化した。そ
して、さらに反応混液500μl で、215ユニツトの
BamHIと37℃で2時間反応させて完全に消化した
のち、0.8%調製用アガロースゲル電気泳動にかけ
て、Apr 、oriを含むDNA断片(2.7Kbp)
を分離精製して、DNAをエタノール沈澱として得、沈
澱を10t/0.1E14.0μl (〜1μg/μl )
に溶解させた。
On the other hand, pUC-8 [JFV VIEIRA and Geochime Measing, Gene (Je
ferry Vieira & Joachim Me
ssing, Gene), 19 , 259 (1982)].
20 μg was added to 200 μl of the reaction mixture to prepare 60 units of P
It was reacted with stI at 37 ° C. for 2 hours for complete digestion. Then, the reaction mixture was further reacted with BamHI of 215 units at 37 ° C. for 2 hours in 500 μl of the reaction mixture to completely digest it, and then subjected to 0.8% preparative agarose gel electrophoresis to obtain a DNA fragment containing Ap r and ori (2. 7Kbp)
Was separated and purified to obtain DNA as an ethanol precipitate, and the precipitate was 10 t / 0.1E14.0 μl (∼1 μg / μl)
Dissolved in.

【0053】そして、pHC−79/cmr Δ(Hin
dIII )のcmr を含むPst/BamHI断片のDN
A溶液1μl (〜1μg)と、pUC−8のApr 、o
riを含むPstI/BamHI断片のDNA溶液1μ
l (〜1μg)とを、反応混液20μl で6ユニツトの
T4−DNAリガーゼと12℃で17.5時間反応させ
て連結した。その後、フエノール抽出を行い、DNAを
エタノール沈澱として得、沈澱を0.1MTris−H
Cl(pH7.5)溶液20μl に溶解させた。次に、
このDNA溶液10μl で大腸菌(HB101)をトラ
ンスホーメーシヨンした後、cmr かつApr クローン
を得た。次いで、これらのクローンのもつプラスミドD
NAの特性を調べて、Apr 、ori及びcmr を有す
るプラスミド:pUC−8/cmr (図5)を持つ大腸
菌を得た。この大腸菌を、TYG−P培地1l 中で増殖
させたのち、菌体よりccc−DNAを分離精製して、
pUC−8/cmr のプラスミドDNAを調製した。
PHC-79 / cm r Δ (Hin
DN of the Pst / BamHI fragment containing the cm r of dIII)
A solution 1 μl (up to 1 μg) and Ap r , o of pUC-8
1μ DNA solution of PstI / BamHI fragment containing ri
1 (.about.1 .mu.g) was ligated by reacting 20 .mu.l of the reaction mixture with 6 units of T4-DNA ligase at 12.degree. C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was extracted with 0.1 M Tris-H.
It was dissolved in 20 μl of Cl (pH 7.5) solution. next,
After transforming E. coli (HB101) with 10 μl of this DNA solution, cm r and Ap r clones were obtained. Then, the plasmid D possessed by these clones
By investigation of the characteristics of the NA, plasmid having Ap r, ori and cm r: obtain a E. coli with pUC-8 / cm r (Fig. 5). After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells,
Plasmid DNA of pUC-8 / cm r was prepared.

【0054】(h)pUC−8/cmr Δ(EcoRI
/PstI)の作成及び調製 pUC−8/cmr 20μgを反応混液200μl で、
60ユニツトのEcoRIと37℃で30分間反応させ
て限定消化した。次いで、フエノール抽出で除蛋白後、
DNAをエタノール沈澱として得た。このDNA沈澱
を、反応混液200μl で35ユニツトのPstIと3
7℃で2時間反応させて完全に消化した。そして、フエ
ノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E10μl (〜1μg/μ
l)に溶解させた。
(H) pUC-8 / cm r Δ (EcoRI
/ PstI) preparation and preparation 20 μg of pUC-8 / cm r in 200 μl of reaction mixture,
It was reacted with 60 units of EcoRI at 37 ° C. for 30 minutes for limited digestion. Then, deproteinize with phenol extraction,
DNA was obtained as an ethanol precipitate. This DNA precipitate was mixed with 35 units of PstI and 3 with 200 μl of the reaction mixture.
The reaction was carried out at 7 ° C for 2 hours for complete digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was collected at 10 t / 0.1E10 μl (up to 1 μg / μm).
l).

【0055】次に、このDNA溶液1.5μl (〜1.
5μg)を、反応混液30μl で〔33mMTris−
acetate(pH7.9)、66mM酢酸カリ、1
0mMMgCl2 、0.5mMDTT、100μg/m
lBSA、0.1mMdATP、0.1mMdCTP、
0.1mMdGTP、0.1mMdTTP〕で、5ユニ
ツトのT4−DNAポリメラーゼ(P・L社製)と、3
7℃で15分間反応させて、cohesive end
をblunt endに変えたのち、0.8%調製用ア
ガロースゲル電気泳動にかけ、Apr 、ori及びcm
r を含むDNA断片(3.85Kbp)を分離精製し
て、DNAをエタノール沈澱として得た。
Next, 1.5 μl of this DNA solution (up to 1.
5 μg) in 30 μl of the reaction mixture [33 mM Tris-
acetate (pH 7.9), 66 mM potassium acetate, 1
0 mM MgCl 2 , 0.5 mM DTT, 100 μg / m
1BSA, 0.1 mM dATP, 0.1 mM dCTP,
0.1 mM dGTP, 0.1 mM dTTP], and 5 units of T4-DNA polymerase (manufactured by PL) and 3
Allow to react for 15 minutes at 7 ° C, then cohesive end
Was changed to blunt end and then subjected to 0.8% preparative agarose gel electrophoresis to give Ap r , ori and cm.
A DNA fragment containing r (3.85 Kbp) was separated and purified to obtain DNA as an ethanol precipitate.

【0056】そして、このDNA沈澱を反応混液50μ
l で15ユニツトのT4−DNAリガーゼと12℃で1
7.5時間反応させて閉環化した。その後、フエノール
抽出を行い、DNAをエタノール沈澱として得、沈澱を
0.1MTris−HCl(pH7.5)溶液20μl
に溶解させた。次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r かつcmr クローンを得た。そして、これらのクロ
ーンのもつプラスミドDNAの特性を調べて、pUC−
8/cmr のEcoRIサイトとPstIサイトの間の
DNA断片(0.75Kbp)を欠いたプラスミド:p
UC−8/cmr Δ(EcoRI/PstI)(図5)
を持つ大腸菌を得た。この大腸菌を、TYG−P培地1
l 中で増殖させたのち、菌体よりccc−DNAを分離
精製して、(pUC−8/cmrΔ(EcoRI/Ps
tI)のプラスミドDNAを調製した。
Then, this DNA precipitate was mixed with 50 μl of the reaction mixture.
15 units of T4-DNA ligase at 1 ° C and 1 at 12 ° C
The reaction was carried out for 7.5 hours for ring closure. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.
Dissolved in. Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, A.
p r and cm r clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pUC-
Plasmid lacking the DNA fragment (0.75 Kbp) between the EcoRI and PstI sites of 8 / cm r : p
UC-8 / cm r Δ (EcoRI / PstI) (Fig. 5)
E. coli having This E. coli was transformed into TYG-P medium 1
After the cells were grown in lcc, ccc-DNA was separated and purified from the cells, and (pUC-8 / cm r Δ (EcoRI / Ps
The plasmid DNA of tI) was prepared.

【0057】(i)pUC−8/cmr Δ(EcoRI
/PstI)Δ(BamHI)の作成及び調製 pUC−8/cmr Δ(EcoRI/PstI)10μ
gを反応混液100μl で150ユニツトのBamHI
と37℃で2間反応させて消化した。そして、フエノー
ル抽出で除蛋白後、DNAをエタノール沈澱として得、
沈澱を10t/0.1E7μl (〜1μg/μl )に溶
解させた。次に、このBamHIで消化したDNA溶液
1μl (〜1μg)を、反応混液25μl で、2ユニツ
トのKlenow酵素と22℃で30分間反応させて、
cohesive endをblunt endに変え
た。そして、反応液を65℃で10分間熱処理してKl
enow酵素を失活させた。
(I) pUC-8 / cm r Δ (EcoRI
/ PstI) Δ (BamHI) Preparation and Preparation pUC-8 / cm r Δ (EcoRI / PstI) 10μ
g of BamHI of 150 units in 100 μl of the reaction mixture
And digested at 37 ° C. for 2 hours. After deproteinization by phenol extraction, DNA was obtained as ethanol precipitate,
The precipitate was dissolved in 10 t / 0.1E7 μl (˜1 μg / μl). Next, 1 μl (to 1 μg) of this BamHI-digested DNA solution was reacted with 2 units of Klenow enzyme at 22 ° C. for 30 minutes with 25 μl of the reaction mixture,
Cohesive end was changed to blunt end. Then, heat the reaction solution at 65 ° C. for 10 minutes to obtain Kl.
The enow enzyme was inactivated.

【0058】そして、この反応液10μl を、反応混液
50μlで15ユニツトのT4−DNAリガーゼと12
℃で17.5時間反応させて閉環化した。その後、フエ
ノール抽出を行い、DNAをエタノール沈澱として得、
沈澱を0.1MTris−HCl(pH7.5)溶液2
0μl に溶解させた。次に、このDNA溶液10μlで
大腸菌(HB101)をトランスホーメーシヨンした
後、Apr かつcmr クローンを得た。そして、これら
のクローンのもつプラスミドDNAの特性を調べて、p
UC−8/cmr Δ(EcoRI/PstI)のBam
HIサイトを欠いたプラスミド:pUC−8/cmr Δ
(EcoRI/Pst)Δ(BamHI)(図5)を持
つ大腸菌を得た。この大腸菌を、TYG−P培地1l 中
で増殖させたのち、菌体よりccc−DNAを分離精製
して、pUC−8/cmr Δ(EcoRI/Pst)Δ
(BamHI)のプラスミドDNAを調製した。
Then, 10 μl of this reaction solution was mixed with 50 μl of the reaction mixture and 15 units of T4-DNA ligase.
The ring was closed by reacting at 17.5 hours for 1 hour. Then, phenol extraction was performed to obtain DNA as ethanol precipitate,
The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 2
It was dissolved in 0 μl. Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and cm r clones were obtained. Then, by examining the characteristics of the plasmid DNA possessed by these clones, p
Bam of UC-8 / cm r Δ (EcoRI / PstI)
Plasmid lacking HI site: pUC-8 / cm r Δ
E. coli with (EcoRI / Pst) Δ (BamHI) (FIG. 5) were obtained. After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells, and pUC-8 / cm r Δ (EcoRI / Pst) Δ
(BamHI) plasmid DNA was prepared.

【0059】(j)pUC−8/cmr Δ(EcoRI
/PstI)Δ(BamHI)/HindIII の作成及
び調整 pUC−8/cmr Δ(EcoRI/PstI)Δ(B
amHI)10μgを反応混液100μl 〔20mMK
Cl、6mMTris−HCl(pH8.0)、6mM
MgCl2 、6mMDTT、100μg/mlBSA〕
で125ユニツトの制限酵素SmaI(New Eng
land Biolabs社製)と37℃で完全に消化
した(blunt end)。そして、フエノール抽出
で除蛋白後、DNAをエタノール沈澱として得、沈澱を
10t/0.1E7μl (〜1μg/μl )に溶解させ
た。
(J) pUC-8 / cm r Δ (EcoRI
/ PstI) Δ (BamHI) / HindIII Preparation and Adjustment pUC-8 / cm r Δ (EcoRI / PstI) Δ (B
amHI) 10 μg reaction mixture 100 μl [20 mMK
Cl, 6 mM Tris-HCl (pH 8.0), 6 mM
MgCl 2 , 6 mM DTT, 100 μg / ml BSA]
With 125 units of restriction enzyme SmaI (New Eng
(manufactured by Land Biolabs) and completely digested at 37 ° C. (blunt end). After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E7 μl (up to 1 μg / μl).

【0060】次に、このDNA溶液0.4μl (〜0.
4μg)とHindIII リンカー〔d(pC−A−A−
G−C−T−T−G)〕2μgとを、反応混液20μl
で、6ユニツトのT4−DNAリガーゼと22℃で6時
間反応させて連結した。そして、この反応液10μl
を、反応混液50μl で15ユニツトのT4−DNAリ
ガーゼと12℃で17.5時間反応させて閉環化した。
その後、フエノール抽出を行い、DNAをエタノール沈
澱として得、沈澱を0.1MTris−HCl(pH
7.5)溶液20μl に溶解させた。
Next, 0.4 μl of this DNA solution (.about.0.
4 μg) and HindIII linker [d (pC-A-A-
G-C-T-T-G)] 2 μg and 20 μl of reaction mixture
Then, it was ligated by reacting with 6-unit T4-DNA ligase at 22 ° C. for 6 hours. And 10 μl of this reaction solution
Was cyclized by reacting with 15 units of T4-DNA ligase in 50 μl of the reaction mixture at 12 ° C. for 17.5 hours.
Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1 M Tris-HCl (pH
7.5) Dissolved in 20 μl of solution.

【0061】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンした後、Ap
r かつcmr クローンを得た。そして、これらのクロー
ンのもつプラスミドDNAの特性を調べて、pUC−8
/cmr Δ(EcoRI/PstI)Δ(BamHI)
のSmaIサイトにHindIII リンカーを挿入させた
プラスミド:pUC−8/cmr Δ(EcoRI/Ps
tI)Δ(BamHI)/HindIII (図4及び図
5)を持つ大腸菌を得た。この大腸菌を、TYG−P培
地1l 中で増殖させたのち、菌体よりccc−DNAを
分離精製して、pUC−8/cmr Δ(EcoRI/P
stI)Δ(BamHI)/HindIII のプラスミド
DNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap
r and cm r clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pUC-8
/ Cm r Δ (EcoRI / PstI) Δ (BamHI)
The SmaI site in the plasmid was inserted the HindIII linker: pUC-8 / cm r Δ (EcoRI / Ps
E. coli with tI) Δ (BamHI) / HindIII (FIGS. 4 and 5) were obtained. After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells and pUC-8 / cm r Δ (EcoRI / P
stI) Δ (BamHI) / HindIII plasmid DNA was prepared.

【0062】(k)pDcos/cmr 作成及び調製 pDcos10μgを反応混液100μlで、60ユニ
ツトのHindIII と37℃で2時間反応させて消化し
た。そして、フエノール抽出で除蛋白後、DNAをエタ
ノール沈澱として得、沈澱を10t/0.1E7μl
(〜1μg/μl)に溶解させた。一方、pUC−8/
cmr Δ(EcoRI/PstI)Δ(BamHI)/
HindIII 20μgを反応混液200μl で、250
ユニツトのHindIII と37℃で2時間反応させて完
全に消化したのち、0.8%調製用アガロースゲル電気
泳動にかけて、cmr を含むDNA断片(1.15Kb
p)を分離精製して、DNAをエタノール沈澱として
得、沈澱を10t/0.1E4.0μl (〜1μg/μ
l )に溶解させた。
(K) Preparation and Preparation of pDcos / cm r 10 μg of pDcos was reacted with 100 μl of the reaction mixture with 60 units of HindIII at 37 ° C. for 2 hours for digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was 10t / 0.1E7 μl.
(˜1 μg / μl). On the other hand, pUC-8 /
cm r Δ (EcoRI / PstI) Δ (BamHI) /
20 μg of HindIII was added to 200 μl of the reaction mixture to give 250
After reacting with Unit's HindIII at 37 ° C. for 2 hours for complete digestion, it was subjected to 0.8% preparative agarose gel electrophoresis to give a DNA fragment containing cm r (1.15 Kb).
p) was separated and purified to obtain DNA as an ethanol precipitate.
l).

【0063】そして、pDcosをHindIII で消化
したDNA溶液1μl (〜1μg)とpUC−8/cm
r Δ(EcoRI/PstI)Δ(BamHI)/Hi
ndIII のcmr を含むHindIII 断片のDNA溶液
1μl (〜1μg)とを、反応混液20μl で6ユニツ
トのT4−DNAリガーゼと12℃で17.5時間反応
させて連結した。その後、フエノール抽出を行い、DN
Aをエタノール沈澱として得、沈澱を0.1MTris
−HCl(pH7.5)溶液20μl に溶解させた。次
に、このDNA溶液10μl で大腸菌(HB101)を
トランスホーメーシヨンした後、Apr かつcmr クロ
ーンを得た。そして、これらのクローンのもつプラスミ
ドDNAの特性を調べて、2個のcos及びApr 、o
ri、cmr を有するプラスミド:pDcos/cmr
(図4)を持つ大腸菌を得た。この大腸菌を、TYG−
P培地1l 中で増殖させたのち、菌体よりccc−DN
Aを分離精製して、pDcos/cmr のプラスミドD
NAを調製した。
Then, 1 μl (~ 1 μg) of a DNA solution obtained by digesting pDcos with HindIII and pUC-8 / cm
r Δ (EcoRI / PstI) Δ (BamHI) / Hi
1 μl (∼1 μg) of a HindIII fragment DNA solution containing cm r of ndIII was ligated by reacting 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, perform phenol extraction and DN
A was obtained as an ethanol precipitate and the precipitate was extracted with 0.1 M Tris.
It was dissolved in 20 μl of -HCl (pH 7.5) solution. Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap r and cm r clones were obtained. Then, the characteristics of the plasmid DNAs possessed by these clones were examined, and two cos and Ap r , o
A plasmid with ri, cm r : pDcos / cm r
E. coli having (Fig. 4) was obtained. This E. coli was designated as TYG-
After being grown in 1 L of P medium, ccc-DN was extracted from the cells.
A was separated and purified to obtain pDcos / cm r of plasmid D
NA was prepared.

【0064】(l)pHCcosの作成及び調製 pRH(−44)10μgを反応混液100μl で、2
3ユニツトのPvuIIと37℃で2時間反応させて完全
に消化したのち、さらに反応混液250μl で、70ユ
ニツトのBamHIと37℃で2時間反応させて完全に
消化したのち、0.8%調製用アガロースゲル電気泳動
にかけてcos及びApr 、oriを含むDNA断片
(2.48Kbp)を分離精製して、DNAをエタノー
ル沈澱として得、沈澱を10t/0.1E4.0μl
(〜1μg/μl )に溶解させた。次に、このDNA溶
液1μl (〜1μg)を反応混液25μl で、2ユニツ
トのKlenow酵素と22℃で30分間反応させてc
ohesive endをblunt endに変え
た。そして、反応液を65℃で10分間熱処理してKl
enow酵素を失活させた。
(L) Preparation and Preparation of pHCcos 10 μg of pRH (−44) was added to 100 μl of the reaction mixture, and 2
After complete digestion with 3 units of PvuII at 37 ° C for 2 hours, 250 μl of reaction mixture was further reacted with 70 units of BamHI at 37 ° C for 2 hours to complete digestion, and then 0.8% for preparation. A DNA fragment (2.48 Kbp) containing cos, Ap r , and ori was separated and purified by agarose gel electrophoresis to obtain DNA as an ethanol precipitate, and the precipitate was 10 t / 0.1E 4.0 μl.
(~ 1 μg / μl). Next, 1 μl (~ 1 μg) of this DNA solution was reacted with 25 μl of the reaction mixture with 2 units of Klenow enzyme at 22 ° C. for 30 minutes, and c
Replaced ohseive end with blunt end. Then, heat the reaction solution at 65 ° C. for 10 minutes to obtain Kl.
The enow enzyme was inactivated.

【0065】このDNA溶液10μl (0.4μg)と
ClaIリンカー〔d(pC−A−T−C−G−A−T
−G)〕2μgとを、反応混液20μl で、6ユニツト
のT4−DNAリガーゼと22℃で6時間反応させて連
結した。そして、この反応液10μl を、反応混液50
μl で15ユニツトのT4−DNAリガーゼと12℃で
17.5時間反応させて閉環化した。その後、フエノー
ル抽出を行い、DNAをエタノール沈澱として得、沈澱
を0.1MTris−HCl(pH7.5)溶液20μ
l に溶解させた。
10 μl (0.4 μg) of this DNA solution and ClaI linker [d (pC-A-T-C-G-A-T]
-G)] 2 µg was ligated with 20 µl of the reaction mixture by reacting with 6 units of T4-DNA ligase at 22 ° C for 6 hours. Then, 10 μl of this reaction solution is added to the reaction mixture 50
This was cyclized by reacting 15 μl of T4-DNA ligase with 12 μl at 12 ° C. for 17.5 hours. After that, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 20 μm.
dissolved in l.

【0066】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンした後、Ap
r クローンを得た。そして、これらのクローンのもつプ
ラスミドDNAの特性を調べて、pRH(−44)のP
vuIIサイトとBamHIサイトの間のDNA断片
(1.72Kbp)を欠き、その場所にClaIリンカ
ーが挿入されたプラスミド:pHCcos(図6)を持
つ大腸菌を得た。この大腸菌を、TYG−P培地1l 中
で増殖させたのち、菌体よりccc−DNAを分離精製
してpHCcosのプラスミドDNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap
An r clone was obtained. Then, the characteristics of the plasmid DNA of these clones were examined, and the pRH (-44) P
Escherichia coli having a plasmid: pHCcos (FIG. 6) in which a DNA fragment (1.72 Kbp) between the vuII site and the BamHI site was deleted and a ClaI linker was inserted at that position was obtained. This Escherichia coli was grown in 1 liter of TYG-P medium, and ccc-DNA was separated and purified from the cells to prepare pHCcos plasmid DNA.

【0067】(m)pBglIICcosの作成及び調製 pHCcos10μgを反応混液100μl で100ユ
ニツトのHindIIIと37℃で2時間反応させて消化
した。そして、フエノール抽出で除蛋白後、DNAをエ
タノール沈澱として得、該沈澱を10t/0.1E7μ
l (〜1μg/μl )に溶解させた。次に、このHin
dIII で消化したDNA溶液1μl (〜1μg)を反応
混液25μl で、2ユニツトのKlenow酵素と22
℃で30分間反応させて、cohesive endを
blunt endに変えた。そして、反応液を65℃
で10分間熱処理してKlenow酵素を失活させた。
(M) Preparation and Preparation of pBglIICcos 10 μg of pHCcos was reacted with 100 μl of the reaction mixture with 100 units of HindIII at 37 ° C. for 2 hours for digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was washed with 10t / 0.1E7μ.
1 (~ 1 µg / µl). Next, this Hin
1 μl (~ 1 μg) of the DNA solution digested with dIII was added to 25 μl of the reaction mixture and 2 units of Klenow enzyme and 22
After reacting at 0 ° C. for 30 minutes, the cohesive end was changed to the blunt end. Then, the reaction solution is heated to 65 ° C.
The Klenow enzyme was inactivated by heat treatment for 10 minutes.

【0068】このDNA溶液10μl (0.4μg)
と、BglIIリンカー〔d(pC−A−G−A−T−C
−T−G)〕2μgとを、反応混液20μl で、6ユニ
ツトのT4−DNAリガーゼと22℃で6時間反応させ
て連結した。そして、この反応液10μl を、反応混液
50μl で15ユニツトのT4−DNAリガーゼと12
℃で17.5時間反応させて閉環化した。その後、フエ
ノール抽出を行い、DNAをエタノール沈澱として得、
沈澱を0.1MTris−HCl(pH7.5)溶液2
0μl に溶解させた。
10 μl (0.4 μg) of this DNA solution
And a BglII linker [d (pC-A-G-A-T-C
-TG)] 2 μg was ligated by reacting with 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 22 ° C. for 6 hours. Then, 10 μl of this reaction solution was mixed with 50 μl of the reaction mixture to prepare 15 units of T4-DNA ligase.
The ring was closed by reacting at 17.5 hours for 1 hour. Then, phenol extraction was performed to obtain DNA as ethanol precipitate,
The precipitate was dissolved in 0.1 M Tris-HCl (pH 7.5) solution 2
It was dissolved in 0 μl.

【0069】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンした後、Ap
r クローンを得た。そして、これらのクローンのもつプ
ラスミドDNAの特性を調べて、pHCcosのHin
dIII サイトにBglIIリンカーを挿入させたプラスミ
ド:pBglIICcos(図6)を持つ大腸菌を得た。
この大腸菌を、TYG−P培地1l で増殖させたのち、
菌体よりccc−DNAを分離精製して、pBglIIC
cosプラスミドDNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, Ap
An r clone was obtained. Then, the characteristics of the plasmid DNA possessed by these clones were investigated, and Hin of pHCcos was examined.
Escherichia coli having a plasmid pBglIICcos (FIG. 6) having a BglII linker inserted at the dIII site was obtained.
After this E. coli was grown in 1 liter of TYG-P medium,
Ccc-DNA was isolated and purified from the bacterial cells to obtain pBglIIC.
Cos plasmid DNA was prepared.

【0070】(n)pBR−327BamHIa の作成
及び調製 pBR−327 10μgを、反応混液100μl 〔6
0mMNaCl、6mMTris−HCl(pH8.
0)、10mMMgCl2 、6mMDTT、100μg
/mlBSA〕で、55ユニツトの制限酵素AvaIと
37℃で2時間反応させて消化した。そして、フエノー
ル抽出で除蛋白後、DNAをエタノール沈澱として得、
沈澱を10t/0.1E7μl (〜1μg/μl )に溶
解させた。次に、このAvaIで消化したDNA溶液1
μl (〜1μg)を、反応混液25μl で、2ユニツト
のKlenow酵素と22℃で30分間反応させて、c
ohesive endをblunt endに変え
た。そして反応液を65℃で10分間熱処理してKle
now酵素を失活させた。
(N) Preparation and Preparation of pBR-327BamHI a 10 μg of pBR-327 was added to 100 μl of the reaction mixture [6
0 mM NaCl, 6 mM Tris-HCl (pH 8.
0) 10 mM MgCl 2 , 6 mM DTT, 100 μg
/ MlBSA] and reacted with 55 units of the restriction enzyme AvaI at 37 ° C. for 2 hours for digestion. After deproteinization by phenol extraction, DNA was obtained as ethanol precipitate,
The precipitate was dissolved in 10 t / 0.1E7 μl (˜1 μg / μl). Next, this DNA solution 1 digested with AvaI
μl (up to 1 μg) was reacted with 25 μl of the reaction mixture with 2 units of Klenow enzyme at 22 ° C. for 30 minutes, and c
Replaced ohseive end with blunt end. Then, heat the reaction solution at 65 ° C. for 10 minutes to obtain Kle.
The now enzyme was inactivated.

【0071】このDNA溶液10μl (0.4μg)
と、BamHIリンカー〔d(pC−G−G−A−T−
C−C−G)〕2μgとを、反応混液20μl で6ユニ
ツトのT4−DNAリガーゼと22℃で6時間反応させ
て連結した。その後、フエノール抽出を行い、DNAを
エタノール沈澱として得た。このDNA沈澱を、反応混
液600μl で1000ユニツトのBamHIと37℃
で4時間反応させて消化したのち、0.8%調製用アガ
ロースゲル電気泳動にかけて、Apr 、oriを含むD
NA断片(2.22Kbp)を分離精製して、DNAを
エタノール沈澱として得た。
10 μl (0.4 μg) of this DNA solution
And a BamHI linker [d (pC-G-G-A-T-
C-C-G)] 2 μg were ligated by reacting with 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 22 ° C. for 6 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. This DNA precipitate was mixed with 600 µl of the reaction mixture and 1,000 units of BamHI and 37 ° C.
After 4 hours of reaction and digestion, it was subjected to 0.8% preparative agarose gel electrophoresis to obtain D containing Ap r and ori.
The NA fragment (2.22 Kbp) was separated and purified to obtain DNA as an ethanol precipitate.

【0072】このDNA沈澱を反応混液20μl で、6
ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて閉環化した後、フエノール抽出を行い、D
NAをエタノール沈澱として得、沈澱を0.1MTri
s−HCl(pH7.5)溶液20μl に溶解させた。
そして、このDNA溶液10μl で大腸菌(HB10
1)をトランスホーメーシヨンしたのち、Apr クロー
ンを得た。次いで、これらのクローンのもつプラスミド
DNAの特性を調べて、pBR327のBamHIサイ
トとAvaIサイトの間のDNA断片(1.05Kb
p)を欠き、その場所にBamHIリンカーを挿入させ
たプラスミド:pBR−327BamHIa(図6)を
持つ大腸菌を得た。この大腸菌を、TYG−P培地1l
中で増殖させたのち、菌体よりccc−DNAを分離精
製してpBR−327BamHIa のプラスミドDNA
を調製した。
This DNA precipitate was treated with 20 μl of the reaction mixture to give 6
After reaction with unit T4-DNA ligase at 12 ° C. for 17.5 hours for cyclization, phenol extraction was performed, and D
NA was obtained as an ethanol precipitate and the precipitate was 0.1 M Tri
It was dissolved in 20 μl of s-HCl (pH 7.5) solution.
Then, with 10 μl of this DNA solution, E. coli (HB10
After transforming 1), an Ap r clone was obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined to find a DNA fragment (1.05 Kb) between the BamHI site and the AvaI site of pBR327.
p) was deleted and a BamHI linker was inserted in its place to obtain Escherichia coli harboring a plasmid: pBR-327BamHI a (FIG. 6). This E. coli was mixed with 1 liter of TYG-P medium.
After grown in medium, plasmid DNA of pBR-327BamHI a the ccc-DNA from the cells was separated and purified
Was prepared.

【0073】(o)pBR−327/BglIICcos
の作製及び調製 pBglIICcos20μgを反応混液200μl で、
65ユニツトのPstIと37℃で2時間反応させて完
全に消化したのち、さらに反応混液500μlで77ユ
ニツトのClaIと37℃で2時間反応させて完全に消
化したのち、0.8%調製用アガロースゲル電気泳動に
かけて、cosを含むDNA断片(0.94Kbp)を
分離精製して、DNAエタノール沈澱として得、沈澱を
10t/0.1E5.0μl (〜1μg/μl )に溶解
させた。
(O) pBR-327 / BglIICcos
Preparation and Preparation of pBglIICcos (20 μg) in a reaction mixture (200 μl)
After reacting with 65 units of PstI at 37 ° C. for 2 hours for complete digestion, 500 μl of the reaction mixture was further reacted with 77 units of ClaI for 2 hours at 37 ° C. for complete digestion and then 0.8% preparative agarose. The cos-containing DNA fragment (0.94 Kbp) was separated and purified by gel electrophoresis to obtain a DNA ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E 5.0 μl (˜1 μg / μl).

【0074】一方、pBR−327BamHIa 20μ
gを反応混液200μl で、70ユニツトのPstIと
37℃で2時間反応させて完全に消化したのち、さらに
反応混液500μl で、85ユニツトのClaIと37
℃で2時間反応させて完全に消化したのち、0.8%調
製用アガロースゲル電気泳動にかけて、oriを含むD
NA断片(1.45Kbp)を分離精製して、DNAを
エタノール沈澱として得、沈澱を10t/0.1E9.
0μl (〜1μg/μl )に溶解させた。
On the other hand, pBR-327BamHI a 20 μ
g of the reaction mixture was reacted with 70 units of PstI at 37 ° C. for 2 hours for complete digestion, and then 500 μl of the reaction mixture was added to 85 units of ClaI.
After 2 hours of reaction at ℃ for complete digestion, 0.8% preparative agarose gel electrophoresis was performed and D containing ori was added.
The NA fragment (1.45 Kbp) was separated and purified to obtain DNA as an ethanol precipitate, which was precipitated with 10 t / 0.1E9.
It was dissolved in 0 μl (˜1 μg / μl).

【0075】そして、pBglIICcosのcosを含
むPst/ClaI断片のDNA溶液1μl (〜1μ
g)と、pBR−327BamHIa のoriを含むP
stI/ClaI断片のDNA溶液1μl (〜1μg)
とを、反応混液20μl で6ユニツトのT4−DNAリ
ガーゼと12℃で17.5時間反応させて連結した。そ
の後、フエノール抽出を行い、DNAエタノール沈澱と
して得、沈澱を0.1MTris−HCl(pH7.
5)溶液20μl に溶解させた。次に、このDNA溶液
10μl で大腸菌(HB101)をトランスホーメーシ
ヨンした後、Aprクローンを得た。次いで、これらの
クローンのもつプラスミドDNAの特性を調べて、co
s及びApr 、oriを有するプラスミド:pBR−3
27/BglIICcos(図4、図6)を持つ大腸菌を
得た。この大腸菌を、TYG−P培地1l 中で増殖させ
たのち、菌体よりccc−DNAを分離精製して、pB
R−327/BglIICcosのプラスミドDNAを調
製した。
Then, 1 μl of DNA solution of Pst / ClaI fragment containing cos of pBglIICcos (1 μl
g) and P containing pBR-327BamHI a ori
DNA solution of stI / ClaI fragment 1 μl (~ 1 μg)
Were ligated by reacting 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain a DNA ethanol precipitate, and the precipitate was 0.1 M Tris-HCl (pH 7.
5) Dissolved in 20 μl of solution. Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, an Ap r clone was obtained. Then, the characteristics of plasmid DNA possessed by these clones were examined, and
Plasmid containing s and Ap r , ori: pBR-3
E. coli with 27 / BglIICcos (FIGS. 4 and 6) was obtained. After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells to obtain pB.
R-327 / BglIICcos plasmid DNA was prepared.

【0076】(p)pTcosApr /ori/cmr
の作成及び調製 pDcos/cmr 20μgを反応混液200μl で、
37ユニツトのClaIと37℃で2時間反応させて完
全に消化したのち、さらに、反応混液500μl で11
0ユニツトのBamHIと37℃で2時間反応させて完
全に消化したのち、0.8%調製用アガロースゲル電気
泳動にかけて、2個のcos及びcmrを含むDNA断
片(1.5Kbp)を分離精製して、DNAをエタノー
ル沈澱として得、この沈澱を10t/0.1E4.0μ
l (〜1μg/μl )に溶解させた。
[0076] (p) pTcosAp r / ori / cm r
Preparation and Preparation of pDcos / cm r 20 μg in a reaction mixture 200 μl,
After reacting with 37 units of ClaI at 37 ° C for 2 hours for complete digestion, the reaction mixture was added with 500 µl of 11
After reacting with 0 unit of BamHI at 37 ° C for 2 hours to completely digest it, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify a DNA fragment (1.5 Kbp) containing two cos and cm r. Then, the DNA was obtained as an ethanol precipitate, and this precipitate was collected at 10 t / 0.1E4.0 μm.
1 (~ 1 µg / µl).

【0077】一方、pBR−327BglIICcos2
0μgを反応混液200μl で、80ユニツトのCla
Iと37℃で2時間反応させて完全に消化したのち、さ
らに反応混液500μl で、240ユニツトのBamH
Iと37℃で2時間反応させて完全に消化したのち、
0.8%調製用アガロースゲル電気泳動にかけて、co
s及びApr 、oriを含むDNA断片(2.0Kb
p)を分離精製して、DNAをエタノール沈澱として
得、沈澱を10t/0.1E12μl (〜1μg/μl
)に溶解させた。そして、pDcos/cmr の2個
のcos及びcmr を含むClaI/BamHI断片の
DNA溶液1μl (〜1μg)と、pBR−327/B
glIICcosのcosおよびApr 、oriを含むC
laI/BamHI断片のDNA溶液1μl (〜1μ
g)とを、反応混液20μl で6ユニツトのT4−DN
Aリガーゼと12℃で17.5時間反応させて連結し
た。その後、フエノール抽出を行い、DNAをエタノー
ル沈澱として得、沈澱を0.1MTris−HCl(p
H7.5)溶液20μl に溶解させた。
On the other hand, pBR-327BglIICcos2
0 μg was added to 200 μl of the reaction mixture to obtain 80 units of Cla.
After digestion with I for 2 hours at 37 ℃, the reaction mixture was further added with 500 µl of 240 units of BamH.
After reacting with I at 37 ° C for 2 hours to completely digest,
Apply 0.8% preparative agarose gel electrophoresis to
DNA fragment containing s, Ap r , and ori (2.0 Kb
p) was separated and purified to obtain DNA as an ethanol precipitate, which was precipitated with 10 t / 0.1E12 μl (∼1 μg / μl).
). Then, 1 μl (to 1 μg) DNA solution of ClaI / BamHI fragment containing two cos and cm r of pDcos / cm r and pBR-327 / B
glIICcos of cos and Ap r, C, including the ori
DNA solution of laI / BamHI fragment 1 μl (up to 1 μl
g) and 20 μl of the reaction mixture with 6 units of T4-DN
Ligation was performed by reacting with A ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1M Tris-HCl (p
H7.5) solution was dissolved in 20 μl.

【0078】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r 、cmr クローンを得た。次いで、これらのクロー
ンのもつプラスミドDNAの特性を調べて、3個のco
s及びApr 、ori、cmrを有するプラスミド:p
TcosApr /ori/cmr (図4)を持つ大腸菌
を得た。この大腸菌を、TYG−P培地1l 中で増殖さ
せたのち、菌体よりccc−DNAを分離精製して、p
TcosApr /ori/cmr プラスミドDNAを調
製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, A.
p r and cm r clones were obtained. Then, the characteristics of the plasmid DNAs possessed by these clones were examined, and the three co
plasmid containing s and Ap r , ori, cm r : p
TcosAp r / ori / cm r was obtained E. coli with (Figure 4). After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells and p.
The TcosAp r / ori / cm r plasmid DNA was prepared.

【0079】(q)pSV010/neoの作製および
調製 pAO43〔オカ、スギサキ アンド タカナミ、ジヤ
ーナル オブ モレキユラー バイオロジー(OKa,
Sugisaki & Takanami,J.Mo
l,Biol),147,214(1981)〕20μ
gを、反応混液200μl 〔60mMNaCl、6mM
Tris−HCl(pH8.0)、10mMMgC
2 、6mMDTT、100μg/mlBSA〕で、1
50ユニツトの制限酵素AvaII(New Engla
nd Biolabs社製)と37℃で2時間反応させ
て消化したのち、0.8%調製用アガロースゲル電気泳
動にかけて、neor を含むDNA断片(1.24Kb
p)を分離精製して、DNAをエタノール沈澱として
得、沈澱を10t/0.1E5μl (〜1μg/μl )
に溶解させた。
(Q) Preparation and Preparation of pSV010 / neo pAO43 [Oka, Sugisaki and Takanami, Journal of Morequiller Biology (OKa,
Sugisaki & Takanami, J. et al. Mo
1, Biol), 147 , 214 (1981)] 20μ
g to 200 μl of reaction mixture [60 mM NaCl, 6 mM
Tris-HCl (pH 8.0), 10 mM MgC
1 2 , 6 mM DTT, 100 μg / ml BSA], 1
50 units of restriction enzyme AvaII (New Engla
nd Biolabs) at 37 ° C. for 2 hours for digestion, and then subjected to 0.8% preparative agarose gel electrophoresis to give a DNA fragment containing neo r (1.24 Kb).
p) is separated and purified to obtain DNA as an ethanol precipitate, and the precipitate is 10t / 0.1E 5 µl (∼1 µg / µl)
Dissolved in.

【0080】このDNA溶液2μl (〜2μg)を、反
応混液50μl で、4ユニツトのKlenow酵素と2
2℃で30分間反応させて、cohesive end
をblunt endに変えた。そして、フエノール抽
出で除蛋白後、DNAをエタノール沈澱として得、沈澱
を10t/0.1E1.5μl (〜μg/μl )に溶解
させた。一方、pSV010{πVX〔ブライヤン シ
ード、ニユクレイツクアシデズ、リサーチ(Brain
seed,Nucleic AcidsRes),
,2427(1983)〕由来のポリリンカーを持つ
たpSV01〔チヤン、アール等、プロシーデイング
オブ ナシヨナル アカデミー サイエンシズ ユー・
エス・エー(Tjan,R,et al,Proc,N
atl,Acad,Sci.U.S.A.)77,64
91(1980)〕の類縁プラスミド}10μgを、反
応混液100μl で129ユニツトのBamHIと37
℃で2時間反応させて消化したのち、フエノール抽出を
行い、DNAをエタノール沈澱として得、沈澱を10t
/0.1E7μl (〜1Mg/μl )に溶解させた。
2 .mu.l (.about.2 .mu.g) of this DNA solution was mixed with 50 .mu.l of the reaction mixture and 4 units of Klenow enzyme and 2
Allow to react at 2 ° C for 30 minutes, cohesive end
Was changed to blunt end. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E1.5 μl (˜μg / μl). On the other hand, pSV010 {πVX [Bryan Seed, Nyukraykku Acids, Research (Brain
seed, Nucleic Acids Res), 1
1 , 2427 (1983)] having a polylinker derived from pSV01 [Jiang, Earl et al., Proceeding]
Of National Academy Sciences You
S.A. (Tjan, R, et al, Proc, N
atl, Acad, Sci. U. S. A. ) 77 , 64
91 (1980)] and 10 .mu.g of the similar plasmid with BamHI of 129 units in 37 .mu.l of the reaction mixture.
After reacting at ℃ for 2 hours for digestion, phenol extraction was performed to obtain DNA as ethanol precipitate, and the precipitate was extracted with 10 t.
/0.1E7 µl (~ 1 Mg / µl).

【0081】このDNA溶液2μl (〜2μg)を反応
混液50μl で、4ユニツトのKlenow酵素と22
℃で30分間反応させて、cohesive endを
blunt endに変えた。そして、フエノール抽出
で除蛋白後、DNAをエタノール沈澱として得、沈澱を
10t/0.1E1.5μl (〜1μg/μl )に溶解
させた。次に、pAO43のneor を含むDNA断片
をKlenow酵素で処理したDNA溶液1μl (〜1
μg)と、pSV010をBamHIで消化し、Kle
now酵素で処理したDNA溶液1μl (〜1μg)と
を、反応液20μl で6ユニツトのT4−DNAリガー
ゼと12℃で17.5時間反応させて連結した。その
後、フエノール抽出を行い、DNAをエタノール沈澱と
して得、その沈澱を0.1MTris−HCl(pH
7.5)溶液20μl に溶解させた。
2 .mu.l (.about.2 .mu.g) of this DNA solution was added to 50 .mu.l of the reaction mixture and 4 units of Klenow enzyme and 22
After reacting at 0 ° C. for 30 minutes, the cohesive end was changed to the blunt end. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E1.5 µl (~ 1 µg / µl). Next, 1 μl of a DNA solution obtained by treating the DNA fragment containing neo r of pAO43 with Klenow enzyme (~ 1
μg) and pSV010 were digested with BamHI and Kle
1 μl (˜1 μg) of the DNA solution treated with now enzyme was ligated by reacting 20 μl of the reaction solution with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1 M Tris-HCl (pH
7.5) Dissolved in 20 μl of solution.

【0082】そして、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r かつKmr (neor )クローンを得た。次いで、
これらのクローンのもつプラスミドDNAの特性を調べ
て、pSV010のBamHIサイトにneor を挿入
させたプラスミド:pSV010/neor (図4)を
持つ大腸菌を得た。この大腸菌を、TYG−P培地1l
中で増殖させたのち、菌体よりccc−DNAを分離精
製してpSV010/neor のプラスミドDNAを調
製した。
Then, E. coli (HB101) was transformed with 10 μl of this DNA solution, and then A
p r and obtained the Km r (neo r) clone. Then
By investigation of the characteristics of plasmid DNA possessed by these clones, the plasmid was inserted the neo r into the BamHI site of pSV010: pSV010 / neo r (FIG. 4) to obtain Escherichia coli with. This E. coli was mixed with 1 liter of TYG-P medium.
After grown in medium, and plasmid DNA was prepared for pSV010 / neo r a ccc-DNA from the cells was separated and purified.

【0083】(r)pTcosApr /ori/cmr
/neor の作成及び調製 pTcosApr /ori/cmr 10μgを反応混液
100μl で、27ユニツトのEcoRIと37℃で3
0分間反応させて限定消化した。そして、フエノール抽
出で除蛋白後、DNAをエタノール沈澱として得、沈澱
を10t/0.1E7μl (〜1μg/μl )に溶解さ
せた。一方、pSV010/neor 20μgを反応混
液200μl で、325ユニツトのEcoRIと37℃
で2時間反応させて完全に消化したのち、0.8%調製
用アガロースゲル電気泳動にかけて、neor を含むD
NA断片(1.3Kbp)を分離精製して、DNAエタ
ノール沈澱として得、沈澱を10t/0.1E5.0μ
l (〜1μg/μl )に溶解させた。
[0083] (r) pTcosAp r / ori / cm r
/ Neo r creation and preparation pTcosAp r / ori / cm r 10μg reaction mixture 100 [mu] l, 3 with EcoRI and 37 ° C. for 27 Yunitsuto
The reaction was allowed to proceed for 0 minutes for limited digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E7 μl (up to 1 μg / μl). On the other hand, in pSV010 / neo r 20μg reaction mixture 200 [mu] l, 325 Yunitsuto of EcoRI and 37 ° C.
After complete digestion by reacting for 2 hours, 0.8% preparative agarose gel electrophoresis was performed and D containing neo r was added.
The NA fragment (1.3 Kbp) was separated and purified to obtain a DNA ethanol precipitate, and the precipitate was 10 t / 0.1E5.0 μ.
1 (~ 1 µg / µl).

【0084】そして、pTcosApr /ori/cm
r をEcoRIで限定消化したDNA溶液1μl (〜1
μg)と、pSV010/neor のneor を含むE
coRI断片のDNA溶液1μl (〜1μg)とを、反
応混液20μl で6ユニツトのT4−DNAリガーゼと
12℃で17.5時間反応させて連結した。その後、フ
エノール抽出を行い、DNAをエタノール沈澱として
得、沈澱を0.1MTris−HCl(pH7.5)溶
液20μl に溶解させた。
[0084] and, pTcosAp r / ori / cm
DNA was limited digested r with EcoRI solution 1μl (~1
and μg), E, including the neo r of pSV010 / neo r
1 μl (˜1 μg) of the DNA solution of the coRI fragment was ligated by reacting 20 μl of the reaction mixture with 6 units of T4-DNA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was dissolved in 20 μl of 0.1 M Tris-HCl (pH 7.5) solution.

【0085】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r 、cmr かつKmr (neor )クローンを得た。
次いで、これらのクローンのもつプラスミドDNAの特
性を調べて、pTcosApr/ori/cmr のEc
oRIサイトにneor が挿入されたプラスミド:pT
cosApr /ori/cmr /neor (図1、図
4)を持つ大腸菌を得た。なお、本菌株は、工業技術院
生命工学工業技術研究所に「微工研菌第7888号(F
ERM P−7888)」として寄託されている。この
大腸菌を、TYG−P培地1l 中で増殖させたのち、菌
体よりccc−DNAを分離精製してpTcosApr
/ori/cmr /neor のプラスミドDNAを調製
した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, A.
p r, to obtain a cm r and Km r (neo r) clone.
Then, by examining the characteristics of plasmid DNA possessed by these clones, pTcosAp r / ori / cm r of Ec
Plasmid with neo r inserted in the ori site: pT
cosAp r / ori / cm r / neo r ( 1, 4) to obtain Escherichia coli with. In addition, this strain was designated by the Institute of Life Science and Technology, Institute of Industrial Science and Technology, under the name of "Micromachine Research No. 7888 (F
ERM P-7888) ". After this E. coli was grown in 1 liter of TYG-P medium, ccc-DNA was separated and purified from the cells to obtain pTcosApr .
/ Ori / cm plasmid DNA of r / neo r was prepared.

【0086】実施例 2 pTcosApr /ori/
TK/cmr /neor の作成および調製(図7) (a)pTK−4/BamHIの作成及び調製 pTK−4〔イシウラ、エム等、モレキユラー アンド
セルラー バイオロジー(Ishiura,M.,e
t al,Mol.Cell Biol)、、607
(1982)〕10μgを反応混液100μl で、3.
0ユニツトのPvuIIと37℃で30分間反応させて限
定消化したのち、0.8%調製用アガロースゲル電気泳
動にかけて、6.43Kbpの長さのDNA断片を分離
精製して、DNAをエタノール沈澱として得、沈澱を1
0t/0.1E3μl (〜1μg/μl )に溶解させ
た。
[0086] Example 2 pTcosAp r / ori /
Creating and preparation TK / cm r / neo r (FIG. 7) (a) pTK-4 / BamHI creation and preparation pTK-4 [Ishiura, M. etc., Morekiyura and Cellular Biology (Ishiura, M., e
t al, Mol. Cell Biol), 2 , 607
(1982)] 10 μg with 100 μl of the reaction mixture, 3.
After reacting with 0 unit of PvuII at 37 ° C. for 30 minutes for limited digestion, it was subjected to 0.8% preparative agarose gel electrophoresis to separate and purify a DNA fragment having a length of 6.43 Kbp, and the DNA was subjected to ethanol precipitation. Get 1 precipitate
It was dissolved in 0t / 0.1E3 µl (~ 1 µg / µl).

【0087】次に、このDNA溶液0.4μl (〜0.
4μg)と、BamHIリンカー〔d(pC−G−G−
A−T−C−C−G)〕2μgとを、反応混液20μl
で6ユニツトのT4−DNAリガーゼと22℃で6時間
反応させて連結した。そして、この反応液10μl を、
反応混液50μl で15ユニツトのT4−DNAリガー
ゼと12℃で17.5時間反応させて閉環化した。その
後、フエノール抽出を行い、DNAをエタノール沈澱と
して得、沈澱を0.1MTris−HCl(pH7.
5)溶液20μl に溶解させた。
Next, 0.4 μl of this DNA solution (.about.0.
4 μg) and a BamHI linker [d (pC-GG-
A-T-C-C-G)] 2 μg and 20 μl of reaction mixture
And ligated by reacting with 6 unit T4-DNA ligase at 22 ° C. for 6 hours. Then, 10 μl of this reaction solution
The reaction mixture was reacted with 15 units of T4-DNA ligase in 50 µl at 12 ° C for 17.5 hours for cyclization. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate, which was precipitated with 0.1 M Tris-HCl (pH 7.
5) Dissolved in 20 μl of solution.

【0088】次に、このDNA溶液10μl で大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r かつTcr クローンを得た。そして、これらのクロ
ーンのもつプラスミドDNAの特性を調べて、pTK−
4のoriとTKとの間のPvuIIサイトにBamHI
リンカーを挿入させたプラスミド:pTK−4/Bam
HI(図7)を持つ大腸菌を得た。この大腸菌を、TY
G−P培地1l 中で増殖させたのち、菌体よりccc−
DNAを分離精製して、pTK−4/BamHIのプラ
スミドDNAを調製した。
Next, after transforming E. coli (HB101) with 10 μl of this DNA solution, A.
p r and Tc r clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pTK-
BamHI at the PvuII site between the 4 ori and TK
Plasmid with inserted linker: pTK-4 / Bam
E. coli with HI (Fig. 7) was obtained. This E. coli is TY
After being grown in 1 liter of G-P medium, ccc-
The DNA was separated and purified to prepare pTK-4 / BamHI plasmid DNA.

【0089】(b)pTK−4/BamHI/BamH
Iの作成及び調製 pTK−4/BamHI10μgを反応混液100μl
で9ユニツトのBamHIと37℃で30分間反応させ
て限定消化したのち、フエノール抽出を行い、DNAを
エタノール沈澱として得た。このエタノール沈澱を反応
混液100μlで15ユニツトのPvuIIと37℃で2
時間反応させて完全に消化したのち、フエノール抽出を
行い、DNAエタノール沈澱として得、沈澱を10t/
0.1E3μl (〜1μg/μl )に溶解させた。
(B) pTK-4 / BamHI / BamH
Preparation and Preparation of I 10 μg of pTK-4 / BamHI in 100 μl of reaction mixture
After reacting with BamHI (9 units) at 37 ° C. for 30 minutes for limited digestion, phenol extraction was performed to obtain DNA as an ethanol precipitate. This ethanol precipitate was mixed with 100 μl of the reaction mixture and 15 units of PvuII at 37 ° C. for 2 times.
After reacting for a time to complete digestion, phenol extraction was performed to obtain a DNA ethanol precipitate.
It was dissolved in 0.1E3 µl (~ 1 µg / µl).

【0090】次に、このBamHIで限定消化し、さら
にPvuIIで消化したDNA溶液1μl (〜1μg)
を、反応混液25μl で2ユニツトのKlenow酵素
と22℃で30分間反応させて、cohesive e
ndをblunt endに変えたのち、0.8%調製
用アガロースゲル電気泳動にかけて、ori及びA
r、TKを含むDNA断片(4.67Kbp)を分離
精製して、DNAをエタノール沈澱として得た。このD
NA沈澱を反応混液20μl で6ユニツトのT4−DN
Aリガーゼと12℃で17.5時間反応させて閉環化し
たのち、(この場合、BamHIサイトが再構成され
る)、フエノール抽出を行い、DNAをエタノール沈澱
として得、沈澱を0.1MTris−HCl(pH7.
5)溶液20μlに溶解させた。
Next, 1 μl (up to 1 μg) of a DNA solution was digested with BamHI and then digested with PvuII.
Was reacted with 2 units of Klenow enzyme in 25 μl of the reaction mixture at 22 ° C. for 30 minutes to obtain cohesive e
After changing nd to blunt end, 0.8% preparative agarose gel electrophoresis was performed to obtain ori and A
p r, was separated and purified the DNA fragment (4.67Kbp) containing TK, which give DNA as ethanol precipitation. This D
The NA precipitate was treated with 20 μl of the reaction mixture to prepare 6 units of T4-DN.
After the reaction with A ligase at 12 ° C. for 17.5 hours for cyclization and cyclization (in this case, the BamHI site is reconstituted), phenol extraction was performed to obtain DNA as an ethanol precipitate, and the precipitate was 0.1 M Tris-HCl. (PH 7.
5) The solution was dissolved in 20 μl.

【0091】そして、このDNA溶液10μl で、大腸
菌(HB101)をトランスホーメーシヨンしたのち、
Apr かつTcs クローンを得た。次いで、これらのク
ローンのもつプラスミドDNAの特性を調べて、pTK
−4/BamHIのPvuIIサイトとBamHIサイト
(Tcr 上)の間のDNA断片(1.76Kbp)を欠
いたプラスミド:pTK−4/BamHI/BamHI
(図7)を持つ大腸菌を得た。この大腸菌を、TYG−
P培地1l 中で増殖させたのち、菌体よりccc−DN
Aを分離精製して、pTK−4/BamHI/BanH
IのプラスミドDNAを調製した。
After transforming E. coli (HB101) with 10 μl of this DNA solution,
Ap r and Tc s clones were obtained. Then, the characteristics of the plasmid DNA possessed by these clones were examined, and pTK
-4 / DNA fragment between the BamHI PvuII site and BamHI site (on Tc r) (1.76Kbp) the lack plasmid: pTK-4 / BamHI / BamHI
E. coli having (Fig. 7) was obtained. This E. coli was designated as TYG-
After being grown in 1 L of P medium, ccc-DN was extracted from the cells.
A is separated and purified to obtain pTK-4 / BamHI / BanH
I plasmid DNA was prepared.

【0092】(c)pTcosApr /ori/TK/
cmr /neor (2BamHI)の作成および調製 pTcosApr /ori/cmr /neor 10μg
を反応混液100μlで60ユニツトのBamHIと3
7℃で2時間反応させて消化した。そして、フエノール
抽出で除蛋白後、DNAをエタノール沈澱として得、沈
澱を10t/0.1E7μl (〜1μg/μl )に溶解
させた。一方、pTK−4/BamHI/BamHI
20μgを反応混液200μl で240ユニツトのBa
mHIと37℃で2時間反応させて完全に消化したの
ち、0.8%調製用アガロースゲル電気泳動にかけて、
TKを含むDNA断片(2.0Kbp)を分離精製し
て、DNAをエタノール沈澱として得、沈澱を10t/
0.1E6.0μl (〜1μg/μl )に溶解させた。
[0092] (c) pTcosAp r / ori / TK /
cm r / neo creation of r (2BamHI) and preparation pTcosAp r / ori / cm r / neo r 10μg
The reaction mixture was mixed with 100 μl of BamHI (60 units) and 3
The reaction was carried out at 7 ° C for 2 hours for digestion. After deproteinization by phenol extraction, DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E7 μl (up to 1 μg / μl). On the other hand, pTK-4 / BamHI / BamHI
20 μg was added to 200 μl of the reaction mixture to prepare 240 units of Ba.
After reacting with mHI at 37 ° C for 2 hours to completely digest, it was subjected to 0.8% preparative agarose gel electrophoresis,
A DNA fragment containing TK (2.0 Kbp) was separated and purified to obtain DNA as an ethanol precipitate.
It was dissolved in 0.1E 6.0 µl (~ 1 µg / µl).

【0093】そして、pTcosApr /ori/cm
r /neor をBamHIで消化したDNA溶液1μl
(〜1μg)と、pTK−4/BamHI/BamHI
のTKを含むBamHI断片のDNA溶液1μl (〜1
μg)とを、反応混液20μl で6ユニツトのT4−D
NAリガーゼと12℃で17.5時間反応させて連結し
た。その後、フエノール抽出を行い、DNAをエタノー
ル沈澱として得、沈澱を0.1MTris−HCl(p
H7.5)溶液20μl に溶解させた。
[0093] and, pTcosAp r / ori / cm
DNA solution 1μl the r / neo r was digested with BamHI
(~ 1 μg) and pTK-4 / BamHI / BamHI
DNA solution of BamHI fragment containing TK of
μg) with 20 μl of the reaction mixture, and 6 units of T4-D
Ligation was performed by reacting with NA ligase at 12 ° C. for 17.5 hours. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate. The precipitate was extracted with 0.1M Tris-HCl (p
H7.5) solution was dissolved in 20 μl.

【0094】次に、このDNA溶液10μl で、大腸菌
(HB101)をトランスホーメーシヨンしたのち、A
r 、cmr かつKmr (neor )クローンを得た。
次いで、これらのクローンのもつプラスミドDNAの特
性を調べて、pTcosAp r /ori/cmr /ne
r のBamHIサイトにTKが挿入されたプラスミ
ド:pTcosApr /ori/TK/cmr /neo
r (2BamHI)(図7)を持つ大腸菌を得た。この
大腸菌を、TYG−P培地1l 中で増殖させたのち、菌
体よりccc−DNAを分離精製して、pTcosAp
r /ori/TK/cmr /neor (2BamHI)
のプラスミドDNAを調製した。
Next, 10 μl of this DNA solution was added to E. coli.
After transforming (HB101), A
pr, CmrAnd Kmr(Neor) A clone was obtained.
Then, the plasmid DNA of these clones was characterized.
Sex, pTcosAp r/ Ori / cmr/ Ne
orWith TK inserted at the BamHI site of
Do: pTcosApr/ Ori / TK / cmr/ Neo
rE. coli with (2BamHI) (Fig. 7) was obtained. this
E. coli was grown in 1 liter of TYG-P medium and
Ccc-DNA is isolated and purified from the body and pTcosAp
r/ Ori / TK / cmr/ Neor(2 BamHI)
Was prepared.

【0095】(d)pTcosApr /ori/TK/
cmr /neor の作成及び調製 pTcosApr /ori/TK/cmr /neo
r (2BamHI)10μgを反応混液100μl で、
14ユニツトのBamHIと37℃で30分間反応させ
て限定消化した。そして、フエノール抽出で除蛋白後、
DNAをエタノール沈澱として得、沈澱を10t/0.
1E7μl (〜1μg/μl )に溶解させた。次に、こ
のBamHIで限定消化したDNA溶液1μl (〜1μ
g)を、反応混液25μl で、2ユニツトのKleno
w酵素と22℃で30分間反応させて、cohesiv
e endをblunt endに変えたのち、0.8
%調製用アガロースゲル電気泳動にかけて、3個のco
s及びApr 、ori、TK、cmr 、neor を含む
DNA断片(6.93Kbp)を分離精製して、DNA
をエタノール沈澱として得た。
[0095] (d) pTcosAp r / ori / TK /
cm r / neo r of creation and preparation pTcosAp r / ori / TK / cm r / neo
r (2BamHI) 10 μg was added to 100 μl of the reaction mixture,
It was reacted with 14 units of BamHI at 37 ° C. for 30 minutes for limited digestion. And after deproteinizing with phenol extraction,
DNA was obtained as an ethanol precipitate, which was precipitated with 10 t / 0.
It was dissolved in 1E7 µl (~ 1 µg / µl). Next, 1 μl of the DNA solution limited to digestion with BamHI (up to 1 μm)
g) with 25 μl of the reaction mixture, 2 units of Kleno
React with w enzyme for 30 minutes at 22 ℃, cohesiv
0.8 after changing e end to blunt end
% Preparative agarose gel electrophoresis to
DNA fragment (6.93 Kbp) containing s and Ap r , ori, TK, cm r , neo r was isolated and purified to obtain DNA.
Was obtained as an ethanol precipitate.

【0096】このDNA沈澱を反応混液20μl で、6
ユニツトのT4−DNAリガーゼと12℃で17.5時
間反応させて閉環化したのち、フエノール抽出を行い、
DNAをエタノール沈澱として得、沈澱を0.1MTr
is−HCl(pH7.5)溶液20μl に溶解させ
た。そして、このDNA溶液10μl で、大腸菌(HB
101)をトランスホーメーシヨンしたのち、Apr
cmr かつKmr (neor )クローンを得た。次い
で、これらのクローンのもつプラスミドDNAの特性を
調べて、pTcosApr /ori/TK/cmr /n
eor (2BamHI)のcmr とTKとの間にあるB
amHIサイトを欠いたプラスミド:pTcosApr
/ori/TK/cmr /neor (図3、図7)を持
つ大腸菌を得た。なお、本菌株は、工業技術院生命工学
工業技術研究所に「微工研菌第7887号(FERM
P−7887)」として寄託されている。この大腸菌
を、TYG−P培地1l 中で増殖させたのち、菌体より
ccc−DNAを分離精製して、pTcosApr /o
ri/TK/cmr /neor のプラスミドDNAを調
製した。
This DNA precipitate was treated with 20 μl of the reaction mixture to give 6
After reaction with unit T4-DNA ligase at 12 ° C. for 17.5 hours to cyclize, followed by phenol extraction,
The DNA was obtained as an ethanol precipitate and the precipitate was extracted with 0.1 MTr.
It was dissolved in 20 μl of is-HCl (pH 7.5) solution. Then, with 10 μl of this DNA solution, E. coli (HB
101) and then Ap r ,
cm r and obtained the Km r (neo r) clone. Then, by examining the characteristics of plasmid DNA possessed by these clones, pTcosAp r / ori / TK / cm r / n
B between cm r of eo r (2 BamHI) and TK
The plasmid lacking the amHI site: pTcosAp r
/ Ori / TK / cm r / neo r ( 3, 7) to give E. coli with. In addition, this strain was designated as "Microindustrial Research Institute No. 7887 (FERM
P-7887) ". The E. coli, after grown in TYG-P medium 1l, was separated and purified ccc-DNA from the cells, pTcosAp r / o
Plasmid DNA of ri / TK / cm r / neo r was prepared.

【0097】実施例 3 pTcosApr /ori/
cmr /neor によるゲノムDNA(外来DNA)の
遺伝子バンクの製造(図2) (a)高分子量のゲノムDNAの調製 pBR−322の塩基配列を持つ、ヘルペスシンプレツ
クウイルス1型(HSV−1)のチミジンキナーゼ(T
K)遺伝子の組換え体を移入したマウスL細胞(Ltk
- 〔HSV−1TK+ 〕)は、10%仔牛血清を添加し
たイーグルMEMで培養し、confluent mo
nolayers(100mm−プレート9枚、〜10
7 cells/プレート)とし、PBS(137mMN
aCl、3mMKCl、8mMNa2 HPO4 、1mM
KH2 PO4 )で2度洗ったのち、可溶化剤〔100μ
g/ml ProteinaseK、0.5%SDS、
150mMNaCl、10mMEDTA、10mMTr
is−HCl(pH7.5)〕をプレート当たり1.0
ml加え、65℃で15〜30分間保温して可溶化し
た。
[0097] Example 3 pTcosAp r / ori /
production of gene bank of cm r / neo r by genomic DNA (exogenous DNA) (Fig. 2) (a) with a nucleotide sequence of the prepared pBR-322 genomic DNA of high molecular weight, herpes thin pre poke virus type 1 (HSV-1 ) Thymidine kinase (T
K) mouse L cells (Ltk
- [HSV-1TK + ]) was cultured in Eagle MEM supplemented with 10% fetal calf serum to obtain fluent mo
Nolayers (100 mm-9 plates, -10
7 cells / plate) and, PBS (137mMN
aCl, 3 mM KCl, 8 mM Na 2 HPO 4 , 1 mM
After washing twice with KH 2 PO 4 ), the solubilizing agent [100 μ
g / ml Proteinase K, 0.5% SDS,
150 mM NaCl, 10 mM EDTA, 10 mM Tr
is-HCl (pH 7.5)] at 1.0 per plate
ml was added, and the mixture was kept warm at 65 ° C. for 15 to 30 minutes for solubilization.

【0098】この可溶化物は50ml容量の遠沈管に移
し、さらに37℃で一晩保温し、途中、Protina
seKをさらに100μg/ml添加した。反応後、等
量のトリス緩衝液で飽和したフエノールでおだやかに2
度抽出し、水層を50mMTris−HCl(pH8.
0)、10mMEDTA、10mMNaClからなる透
析緩衝液3l に対して4回透析を行つた。透析内液は、
50μg/mlのDNase−free RNaseA
を加えて、37℃で3時間保温してRNAを分解した。
反応後、等量のフエノール:クロロホルム混液で2度お
だやかに抽出し、水層を10mMTris−HCl(p
H8.0)、1mMEDTAからなる水溶液(TE)3
l に対して9回透析して、精製DNA溶液50mlを得
た。DNA溶液の260nmと280nmでの吸光度
(OD)は、10倍希釈でそれぞれ0.667、0.3
63(OD280 /OD260 =0.544)であり、DN
Aの濃度は0.667×0.050(μg/l OD)×
10=0.334μg/μlであつた。
The solubilized product was transferred to a centrifuge tube having a volume of 50 ml and further incubated at 37 ° C. overnight, and in the middle of the process, Proteina was used.
seK was further added at 100 μg / ml. After the reaction, gently add 2 volumes of phenol saturated with an equal volume of Tris buffer.
Once, the aqueous layer is extracted with 50 mM Tris-HCl (pH 8.
0) Dialysis was carried out 4 times against 3 l of dialysis buffer consisting of 10 mM EDTA and 10 mM NaCl. The dialysis fluid is
50 μg / ml DNase-free RNaseA
Was added and the mixture was kept warm at 37 ° C. for 3 hours to decompose RNA.
After the reaction, the mixture was gently extracted twice with an equal volume of phenol: chloroform, and the aqueous layer was washed with 10 mM Tris-HCl (p
H8.0) Aqueous solution (TE) 3 consisting of 1 mM EDTA
It was dialyzed 9 times against l to obtain 50 ml of purified DNA solution. The absorbance (OD) of the DNA solution at 260 nm and 280 nm was 0.667 and 0.3 at 10-fold dilution, respectively.
63 (OD 280 / OD 260 = 0.544) and DN
The concentration of A is 0.667 × 0.050 (μg / l OD) ×
10 = 0.334 μg / μl.

【0099】(b)35〜45KbpのゲノムDNAの
調製 精製したゲノムDNA溶液5.98ml(2mg)を、
反応混液29.96ml〔50mMNaCl、10mM
Tris−HCl(pH7.5)、10mMMgC
2 、100μg/mlBSA〕で15.6ユニツトの
Sau3A(NewEngland Biolabs社
製)と37℃で1時間反応させて限定消化したのち、
0.5MEDTA(pH8.0)溶液を1.3ml加
え、等量のトリス緩衝液飽和フエノールで2度おだやか
に抽出した。そして、水層をセカンダリーブタノールで
10mlまで濃縮したのち、3.0M酢酸ナトリウム
1.1mlとエタノール20mlを加え、エタノール沈
澱としてゲノムDNAを得、70%エタノールで洗つた
のち、水流ポンプにて乾燥を行い、エタノール沈澱をT
E2mlに溶解させた。
(B) Preparation of 35-45 Kbp Genomic DNA Purified genomic DNA solution (5.98 ml, 2 mg) was added to
Reaction mixture 29.96 ml [50 mM NaCl, 10 mM
Tris-HCl (pH 7.5), 10 mM MgC
l 2 , 100 μg / ml BSA] was reacted with Sau3A (manufactured by New England Biolabs) of 15.6 unit for 1 hour at 37 ° C. for limited digestion,
1.3 ml of 0.5 M EDTA (pH 8.0) solution was added, and the mixture was gently extracted twice with an equal volume of Tris buffer saturated phenol. Then, after concentrating the aqueous layer to 10 ml with secondary butanol, 1.1 ml of 3.0 M sodium acetate and 20 ml of ethanol were added to obtain genomic DNA as an ethanol precipitate, which was washed with 70% ethanol and dried with a water pump. Perform ethanol precipitation
It was dissolved in 2 ml of E.

【0100】次に、このDNA溶液300μl を5〜2
5%シヨ糖密度勾配遠心〔20mMTris−HCl
(pH7.6)、5mMEDTA、ベツクマンSW2
8;20,000rpm、9時間、20℃〕にかけて3
0滴ごとに分画した。各分画20μl を0.4%アガロ
ースゲル電気泳動にかけて長さを測定し、35〜45K
bpの大きさのDNA分画を集めたのち、TE3l に対
して3回透析を行った。そして、透析内液をフエノール
抽出後、水層をセカンダリーブタノールで濃縮し、DN
Aをエタノール沈澱として得、沈澱をTE1mlに溶解
させて、35〜45KbpのゲノムDNA溶液を得た。
DNA溶液のOD260 及びOD280 は50倍希釈でそれ
ぞれ0.216、0.112(OD280 /OD260
0.519)であり、DNAの濃度は0.216×0.
050(μg/l OD)×50=0.54μg/μl で
あつた。
Next, 300 μl of this DNA solution was added to 5-2.
5% sucrose density gradient centrifugation [20 mM Tris-HCl
(PH 7.6), 5 mM EDTA, Beckmann SW2
8; 20,000 rpm, 9 hours, 20 ° C.] 3
It fractionated every 0 drops. 20 μl of each fraction was subjected to 0.4% agarose gel electrophoresis and the length was measured.
After collecting a bp-sized DNA fraction, it was dialyzed against TE3l three times. After the dialysis solution was extracted with phenol, the aqueous layer was concentrated with secondary butanol to give DN.
A was obtained as an ethanol precipitate, and the precipitate was dissolved in TE1 ml to obtain a genomic DNA solution of 35 to 45 Kbp.
The OD 260 and OD 280 of the DNA solution were 0.216 and 0.112 (OD 280 / OD 260 =
0.519), and the concentration of DNA is 0.216 × 0.
050 (μg / l OD) × 50 = 0.54 μg / μl.

【0101】(c)コスミドベクターDNAの調製 pTcosApr /ori/cmr /neor 40μg
を反応混液400μlで80ユニツトのClaIと37
℃で2時間反応させて消化した。その後、フエノール抽
出を行い、DNAをエタノール沈澱として得、沈澱を1
0t/0.1E100μl に溶解させた。このClaI
で消化したDNA溶液95μl を、反応混液500μl
〔50mMTris−HCl(pH9.0)、1mMM
gCl2、0.1mMZnCl2 、1mMスペルジミ
ン〕で、6ユニツトのホスフアターゼ(Calf in
testinal alkaline phospha
tase,Boehringer Mannheim社
製)と、37℃で15分間反応後、56℃で15分間反
応後、さらに6ユニツトのホスフアターゼを加え、37
℃で15分間反応させて、ClaIの切断片を不活化し
た。
[0102] (c) Preparation of cosmid vector DNA pTcosAp r / ori / cm r / neo r 40μg
The reaction mixture was mixed with 80 μl of ClaI and 400 μl of the reaction mixture.
The reaction was carried out at 0 ° C for 2 hours for digestion. Then, phenol extraction was performed to obtain DNA as an ethanol precipitate.
It was dissolved in 100 μl of 0t / 0.1E. This ClaI
95μl of DNA solution digested with
[50 mM Tris-HCl (pH 9.0), 1 mMM
gCl 2 , 0.1 mM ZnCl 2 , 1 mM sperdimine], and 6 units of phosphatase (Calf in
testal alkaline phospha
Tase, Boehringer Mannheim) and after reacting at 37 ° C. for 15 minutes and at 56 ° C. for 15 minutes, 6 units of phosphatase were further added, and 37
The ClaI fragment was inactivated by reacting at 15 ° C for 15 minutes.

【0102】その後、H2 O400μl 、STE〔10
0mMTris−HCl(pH8.0)、1MNaC
l、10mMEDTA〕100μl 、10%SDS50
μl を加え、68℃で15分間保温して、ホスフアター
ゼを失活させた。そして、フエノール抽出で除蛋白後、
DNAをエタノール沈澱として得、沈澱を10t/0.
1E30μl に溶解した。次に、このClaIで消化
し、ホスフアターゼで不活化したDNA溶液30μl
を、反応混液500μl で、176ユニツトのBamH
Iと37℃で2時間反応させて消化した。そして、フエ
ノール抽出で除蛋白後、DNAをエタノール沈澱として
得、沈澱を10t/0.1E30μl に溶解させて、コ
スミドベクターDNA溶液を得た(0.69μg/μl
)。
Then, 400 μl of H 2 O and STE [10
0 mM Tris-HCl (pH 8.0), 1 M NaC
1, 10 mM EDTA] 100 μl, 10% SDS50
μl was added and the mixture was incubated at 68 ° C. for 15 minutes to inactivate the phosphatase. And after deproteinizing with phenol extraction,
DNA was obtained as an ethanol precipitate, which was precipitated with 10 t / 0.
It was dissolved in 30 μl of 1E. Next, 30 μl of this DNA solution digested with ClaI and inactivated with phosphatase
With 500 μl of reaction mixture, BamH of 176 units
It was digested by reacting with I at 37 ° C. for 2 hours. After deproteinization by phenol extraction, the DNA was obtained as an ethanol precipitate, and the precipitate was dissolved in 10 t / 0.1E30 μl to obtain a cosmid vector DNA solution (0.69 μg / μl).
).

【0103】(d)35〜45KbpのゲノムDNAと
コスミドベクターDNAとの連結 (b)で調製した35〜45Kbpのゲノム溶液2.6
1μl (1.4μg)と、(c)で調製したコスミドベ
クターDNA0.86μl (0.59μg)とを、反応
混液10μl で5.9ユニツトのT4−DNAリガーゼ
と12℃で17.5時間反応させて連結した。反応終了
後、反応液を4℃で保存した。
(D) Ligation of 35-45 Kbp genomic DNA with cosmid vector DNA 2.6-35 Kbp genomic solution prepared in (b) 2.6
1 μl (1.4 μg) and 0.86 μl (0.59 μg) of the cosmid vector DNA prepared in (c) were reacted with 10 μl of the reaction mixture with 5.9 unit T4-DNA ligase at 12 ° C. for 17.5 hours. Connected. After the reaction was completed, the reaction solution was stored at 4 ° C.

【0104】(e)パッケージング抽出液の調製 (1)BHB2690から超音波処理して得られる菌体
抽出液の調製 大腸菌BHB2690をNZY培地(1%NZamin
e、0.5%酵母エキス、0.5%NaCl、0.2%
MgCl2 ・6H2 O、pH7.5)100mlで一晩
培養した液のOD600 を測定後、あらかじめ32℃に保
温しておいたNZY培地500ml(2l フラスコ中)
に最初のOD600 が0.025になるように菌を接種
し、32℃で振とう培養を開始した。そして、OD600
が、0.3になった時点で(培養開始から2時間40分
後)、45℃で15分間おきプロフアージの誘導を行っ
た。その後、培養温度を38〜39℃に変え、さらに3
時間激しく振とう培養した(培養液の少量にクロロホル
ムを一滴、滴下することによつて誘導の検査をした)。
(E) Preparation of packaging extract (1) Preparation of cell extract obtained by sonicating BHB2690 E. coli BHB2690 was diluted with NZY medium (1% NZamin).
e, 0.5% yeast extract, 0.5% NaCl, 0.2%
After measuring the OD 600 of an overnight culture solution in 100 ml of MgCl 2 · 6H 2 O, pH 7.5, 500 ml of NZY medium preheated to 32 ° C (in a 2 l flask)
Bacteria were inoculated so that the initial OD 600 was 0.025, and shaking culture was started at 32 ° C. And OD 600
However, when it reached 0.3 (2 hours and 40 minutes after the start of culture), induction of profage was carried out at 45 ° C. for 15 minutes. After that, the culture temperature was changed to 38 to 39 ° C., and further 3
The culture was vigorously shaken for a period of time (induction was examined by adding one drop of chloroform to a small amount of the culture medium).

【0105】培養終了後、6,000rpmで10分間
遠心分離機にかけて集菌を行い、菌体を20mMTri
s−HCl(pH8.0)、1mMEDTA、5mMβ
−メルカプトエタノールからなる緩衝液3.6mlに懸
濁液させた。そして、4℃以下で超音波処理(最大出力
で5秒間×20回)を行つたのち、20,000rpm
で10分間遠心分離機にかけて(4℃)、上澄液〜3m
lを得た。次に、上澄液3mlに等量の上記緩衝液とパ
ツケージング緩衝液〔6mMTris−HCl(pH
8.0)、50mMスペルミジン、50mMプトレシ
ン、20mMMgCl2 、30mMATP、30mMβ
−メルカプトエタノール〕0.5mlを加えたのち、1
5μl ずつ1.5mlのエツペンドルフチユーブに分注
し、直ちに液体窒素中で冷凍し、−70℃で保存した。
After completion of the culture, the cells were collected by centrifuging at 6,000 rpm for 10 minutes to collect the cells at 20 mM Tri.
s-HCl (pH 8.0), 1 mM EDTA, 5 mM β
-Suspension in 3.6 ml of a buffer consisting of mercaptoethanol. Then, after performing ultrasonic treatment (maximum output for 5 seconds × 20 times) at 4 ° C. or less, 20,000 rpm
Centrifuge for 10 minutes at 4 ° C (up to 3m)
1 was obtained. Next, in 3 ml of the supernatant, an equal amount of the above-mentioned buffer and packaging buffer [6 mM Tris-HCl (pH
8.0), 50 mM spermidine, 50 mM putrescine, 20 mM MgCl 2 , 30 mM ATP, 30 mM β
-Mercaptoethanol] 0.5 ml and then 1
5 μl of each was dispensed into 1.5 ml of Eppendorf tube, immediately frozen in liquid nitrogen, and stored at −70 ° C.

【0106】(2)BHB2688から凍結・融解によ
つて得られる菌体抽出液の調製 大腸菌2688を、NZY培地100mlで一晩培養し
た液のOD600 を測定したのち、あらかじめ32℃に保
温しておいたNZY培地500ml(2l フラスコ中)
に最初のOD600 が0.025になるように菌を接種
し、32℃で振とう培養を開始した。そして、OD600
が0.3になった時点で(培養開始から2時間40分
後)、45℃で15分間おきプロフアージの誘導を行つ
た。その後、培養温度を38〜39℃に変え、さらに3
時間激しく振とう培養した(培養液の少量にクロロホル
ムを一滴、滴下することによつて誘導の検査をした)。
(2) Preparation of bacterial cell extract obtained from BHB2688 by freezing and thawing Escherichia coli 2688 was cultured overnight in 100 ml of NZY medium, the OD 600 of which was measured, and then preliminarily kept at 32 ° C. 500 ml of plated NZY medium (in a 2 l flask)
Bacteria were inoculated so that the initial OD 600 was 0.025, and shaking culture was started at 32 ° C. And OD 600
When it reached 0.3 (2 hours and 40 minutes after the start of culture), induction of profage was carried out at 45 ° C. for 15 minutes. After that, the culture temperature was changed to 38 to 39 ° C., and further 3
The culture was vigorously shaken for a period of time (induction was examined by adding one drop of chloroform to a small amount of the culture medium).

【0107】培養終了後、6,000rpmで10分間
遠心分離機にかけて集菌を行い、菌体をシヨ糖溶液〔1
0%シヨ糖、50mMTris−HCl(pH8.
0)〕3mlに懸濁させたのち、0.5mlずつエツペ
ンドルフチユーブ6本にとり、この各々のチユーブにリ
ゾチーム溶液〔2mg/ml、0.25MTris−H
Cl(pH8.0)〕25μl を加え(4℃)、おだや
かに混合し、すばやく液体窒素中にて凍結させた。次
に、チユーブを氷上において抽出物を融解させたのち、
各チユーブにパツケージング緩衝液25μl を加えて混
合した。そして、各抽出物を一緒にして、21,000
rpmで1時間(4℃)遠心分離機にかけて上澄液を
得、これの10μl ずつを1.5mlのエツペンドルフ
チユーブに分注し、直ちに液体窒素中で冷凍し、−70
℃で保存した。
After completion of the culture, the cells were collected by centrifuging at 6,000 rpm for 10 minutes to collect the cells, and the sucrose solution [1
0% sucrose, 50 mM Tris-HCl (pH 8.
0)] After being suspended in 3 ml, 0.5 ml of each of Eppendorf tubes was placed in 6 tubes, and a lysozyme solution [2 mg / ml, 0.25 MTris-H was added to each tube.
Cl (pH 8.0)] 25 μl was added (4 ° C.), mixed gently and quickly frozen in liquid nitrogen. Next, thaw the tube on ice to thaw the extract,
25 μl of packaging buffer was added to each tube and mixed. And each extract is put together to 21,000
A supernatant was obtained by centrifuging at rpm for 1 hour (4 ° C.), and 10 μl of the supernatant was dispensed into 1.5 ml of Eppendorf tube and immediately frozen in liquid nitrogen.
Stored at ° C.

【0108】(f)in vitroパツケージング −70℃に保存しておいたBHB2690とBHB26
88の菌体抽出液を氷上におき、まず先に融解するBH
B2688の抽出液をBHB2690の抽出液に加え
て、おだやかに混合した。ほぼ全部融解したところで、
(d)で調製した組換え体DNA溶液2.5μl (0.
5μg)を加えてよく混合したのち、室温で1時間反応
させてin vitroパツケージングを行つた。反応
終了後、SM溶液〔0.58%NaCl、0.2%Mg
SO4 ・7H2 O、50mMTris−HCl(pH
7.5)0.01%ゲラチン〕1mlとクロロホルム一
滴を加えて混合した。そして、エツペンドルフチユーブ
を机上遠心機に30秒間かけて、上澄液を形質導入フア
ージ粒子溶液として得た。
(F) In vitro packaging BHB2690 and BHB26 stored at -70 ° C.
BH that 88 cell extract is put on ice and thawed first
The B2688 extract was added to the BHB2690 extract and gently mixed. When almost everything melted,
2.5 μl of the recombinant DNA solution prepared in (d) (0.
5 μg) was added and mixed well, and the mixture was allowed to react at room temperature for 1 hour for in vitro packaging. After completion of the reaction, SM solution [0.58% NaCl, 0.2% Mg
SO 4 · 7H 2 O, 50mMTris -HCl (pH
7.5) 0.01% Gelatin] 1 ml and 1 drop of chloroform were added and mixed. Then, the Eppendorf tube was put on a desk centrifuge for 30 seconds to obtain a supernatant as a transduction-charge particle solution.

【0109】(g)形質導入及びプレーテイング 大腸菌HB101のL−ブロス(マルトース0.4%添
加)で一晩培養した液200μl を机上遠心機にかけて
集菌を行い、その菌体を10mMMgCl2 溶液100
μl に再懸濁した。次に、この菌体懸濁液100μl に
SM溶液で10倍希釈した形質導入フアージ粒子溶液1
00μl を加え、37℃で15分間保温して形質導入を
行つたのち、さらにL−ブロス1.1mlを加え、37
℃で45分間振とう培養した。そして、この菌体懸濁液
を100μl ずつアンピシリン20μg/ml含有する
100mmのL−プレートに塗布し、プレートを37℃
で一晩おいたのち、生ずるコロニーを竹ぐしでついてL
−ブロス(アンピシリン20μg/ml含有)で増殖さ
せた。また、プレート当たりのコロニー数は20〜10
0個であった。
(G) Transduction and plating 200 μl of an overnight culture of Escherichia coli HB101 in L-broth (with 0.4% maltose added) was collected on a desk centrifuge to collect 100 cells of 10 mM MgCl 2 solution.
Resuspended in μl. Next, 100 μl of this bacterial cell suspension was diluted 10-fold with SM solution to give a solution 1 for the transduction phage particles.
After adding 00 μl and incubating at 37 ° C. for 15 minutes for transduction, 1.1 ml of L-broth was further added, and 37
The cells were shaken at 45 ° C for 45 minutes. Then, 100 μl of this cell suspension was applied to a 100 mm L-plate containing 20 μg / ml of ampicillin, and the plate was kept at 37 ° C.
After overnight, attach the resulting colony with a bamboo stick and
-Grown in broth (containing 20 μg / ml ampicillin). The number of colonies per plate is 20-10
It was 0.

【0110】(h)トランスホーマントの培養及び、そ
れの持つプラスミドDNAの調製と特性化 (g)で得られたアンピシリン耐性コロニー(トランス
ホーマント)20個を、L−ブロス(アンピシリン20
μg/ml含有)2mlで一晩培養した後、各培養液
1.5mlのエツペンドルフチユーブにとり、机上遠心
機にかけて集菌した。これらの菌体を溶液I〔50mM
グルコース、25mMTris−HCl(pH8.
0)、10mMEDTA、4mg/mlリゾチーム)1
00μl に再懸濁したのち、室温で5分間おいた。次
に、溶液II(0.2NNaOH、1%SDS)200μ
l を加えておだやかに混合し、氷上に5分間おいたの
ち、溶液III〔5M酢酸カリ(pH4.8)〕150μl
を加えておだやかに混合し、氷上に5分間おいた。そ
して、エツペンドルフチユーブを机上遠心機にかけて上
澄液を得、これに2倍容量のエタノールを加えて、プラ
スミドDNAをエタノール沈澱として得た。
(H) Cultivation of transformant and preparation and characterization of plasmid DNA carried by the transformant.
After culturing overnight in 2 ml (containing μg / ml), each culture solution was placed in 1.5 ml of Eppendorf tube and centrifuged on a desk to collect the cells. Add these cells to solution I [50 mM
Glucose, 25 mM Tris-HCl (pH 8.
0) 10 mM EDTA, 4 mg / ml lysozyme) 1
After resuspending in 00 μl, the mixture was placed at room temperature for 5 minutes. Next, Solution II (0.2N NaOH, 1% SDS) 200μ
l, gently mixed and kept on ice for 5 minutes, and then solution III [5M potassium acetate (pH 4.8)] 150 μl
And gently mixed and placed on ice for 5 minutes. Then, Eppendorf tube was subjected to a desk centrifuge to obtain a supernatant liquid, and 2 volumes of ethanol was added thereto to obtain a plasmid DNA as an ethanol precipitate.

【0111】各トランスホーマントのもつプラスミドD
NAを少量の10t/0.1Eに溶解させたのち、サイ
ズマーカーDNA(ラムダDNA:48Kbp、ラムダ
DNAをHindIII で消化したもの:22.3Kb
p、9.5Kbp)と一緒に、0.4%アガロースゲル
電気泳動にかけたところ、アンピシリン耐性コロニー2
0個のうち、すべてが22.3Kbp〜48Kbpの大
きさのところにプラスミドDNAの存在が認められた。
この段階では、組換え体DNAはプラスミドとして存在
しており、外来DNAの遺伝子バンクはプラスミドDN
Aとして製造されている。
Plasmid D of each transformant
NA was dissolved in a small amount of 10 t / 0.1E and then size marker DNA (lambda DNA: 48 Kbp, lambda DNA digested with HindIII: 22.3 Kb
p, 9.5 Kbp) and subjected to 0.4% agarose gel electrophoresis to give ampicillin resistant colonies 2
The presence of plasmid DNA was observed at a size of 22.3 Kbp to 48 Kbp among all 0.
At this stage, the recombinant DNA exists as a plasmid, and the gene bank of the foreign DNA is the plasmid DN.
Manufactured as A.

【0112】(i)形質導入及びin vivoパツケ
ージング 大腸菌HB101にラムダフアージが溶原化している菌
株LN900〔HB101(λCIts、Tcr ):30
℃ではラムダフアージは溶原化しているが、37℃では
ラムダフアージは溶菌化サイクルに移行する。また、テ
トラサイクリン耐性である。〕をL−ブロス(マルトー
ス0.4%添加)にて30℃で一晩培養した。その培養
液200μl を机上遠心機にかけて集菌を行い、その菌
体を10mMMgCl2 溶液100μl に再懸濁した。
[0112] (i) strain Ramudafuaji to transduction and in vivo Patsukejingu E. coli HB101 is lysogenic LN900 [HB101 (λCI ts, Tc r) : 30
At 37 ° C, lambda quartage is lysogenized, but at 37 ° C, lambda quartet shifts to the lysis cycle. It is also tetracycline resistant. ] Was cultured overnight at 30 ° C. in L-broth (0.4% maltose added). 200 μl of the culture solution was put on a desk centrifuge to collect the cells, and the cells were resuspended in 100 μl of a 10 mM MgCl 2 solution.

【0113】次に、この菌体懸濁液100μl に、
(f)で調製した形質導入フアージ粒子溶液(SM溶液
で10倍希釈)100μl を加え、30℃で15分間保
温して形質導入を行つたのち、さらにL−ブロス1.1
mlを加え、30℃で45分間振とう培養した。その
後、最終濃度が20μg/mlになるようにアンピシリ
ン及びクロラムフエニコールを添加し、全液量2ml
(L−ブロス:マルトース0.4%添加)で30℃にお
いて一晩培養した。
Next, to 100 μl of this cell suspension,
After adding 100 μl of the transfection phage particle solution prepared in (f) (10-fold dilution with SM solution) and incubating at 30 ° C. for 15 minutes for transduction, L-broth 1.1 was further added.
ml was added, and the mixture was shake-cultured at 30 ° C. for 45 minutes. After that, ampicillin and chloramphenicol were added so that the final concentration was 20 μg / ml, and the total volume was 2 ml.
(L-broth: 0.4% maltose added) was cultured overnight at 30 ° C.

【0114】次に、この培養液25μl を、あらかじめ
30℃に保温しておいたL−ブロス(マルトース0.4
%、アンピシリン20μg/ml、クロラムフエニコー
ル20μg/ml添加)5mlに接種し、30℃で振と
う培養を開始した。そして、OD600 が0.3になった
時点で(培養開始から3時間後)、40℃で10分間お
いてインダクシヨン(誘発)を行つたのち、培養温度を
37℃に変えて30分間振とう培養した。そして、この
培養液100μl に、あらかじめ37℃に保温しておい
たL−ブロス(マルトース0.4%添加)9.9mlを
加え、さらに37℃で2時間振とう培養したのち、クロ
ロホルムを数滴加えて混合した。
Next, 25 μl of this culture solution was added to L-broth (maltose 0.4
%, Ampicillin (20 μg / ml, chloramphenicol 20 μg / ml) was inoculated into the mixture, and shaking culture was started at 30 ° C. Then, when the OD 600 reached 0.3 (3 hours after the start of culture), the mixture was allowed to stand at 40 ° C. for 10 minutes for induction, and then the culture temperature was changed to 37 ° C. and shaken for 30 minutes. Cultured. Then, to 100 μl of this culture solution, 9.9 ml of L-broth (0.4% maltose added) which had been kept warm at 37 ° C. was added, and after further shaking culture at 37 ° C. for 2 hours, several drops of chloroform were added. In addition, mixed.

【0115】次に、この液を遠心分離機(4,500r
pm、10分間)にかけて、上澄液を形質導入フアージ
粒子溶液として得た。また、この形質導入フアージ粒子
溶液50μl に、30℃で一晩培養しておいた大腸菌L
N900の培養液1mlを加え、30℃で5分間保温し
て形質導入を行つたのち、この菌体懸濁液を50μlず
つL−プレート(アンピシリン20μg/μl 含有)に
塗布し、プレートを30℃において一晩おいたところ、
プレート当たり1,000〜3,000個のコロニーが
認められた。この段階において、組換え体DNAは形質
導入フアージ粒子として存在しており、外来DNAの遺
伝子バンクは形質導入フアージ粒子として製造される。
Next, this solution was centrifuged (4,500 r).
pm, 10 min) to obtain the supernatant as a solution of transduction fare particles. In addition, 50 μl of this transfection phage particle solution was incubated with E. coli L at 30 ° C. overnight.
After adding 1 ml of N900 culture solution and incubating at 30 ° C. for 5 minutes for transduction, 50 μl of this bacterial cell suspension was applied to L-plate (containing 20 μg / μl of ampicillin), and the plate was heated to 30 ° C. I left it overnight at
1,000 to 3,000 colonies were observed per plate. At this stage, the recombinant DNA is present as transduction phage particles and the gene bank of foreign DNA is produced as transduction phage particles.

【図面の簡単な説明】[Brief description of drawings]

【図1】新規コスミドベクターpTcosApr /or
i/cmr /neor を示すものである。
FIG. 1 is a new cosmid vector pTcosAp r / or
shows the i / cm r / neo r.

【図2】図1の新規コスミドベクターを用いるゲノムD
NAの遺伝子バンクの製造方法を示すものである。
FIG. 2 Genome D using the novel cosmid vector of FIG.
1 shows a method for producing a NA gene bank.

【図3】新規コスミドベクターpTcosApr /or
r /TK/cmr /neorを示すものである。
FIG. 3 is a new cosmid vector pTcosAp r / or
i r / TK / cm r / ne o r .

【図4】pTcosApr /ori/cmr /neor
の作成方法を示すものである。
[Figure 4] pTcosAp r / ori / cm r / neo r
It shows how to create.

【図5】図4に続くpTcosApr /ori/cmr
/neor の作成方法を示すものである。
[Figure 5] subsequent to FIG. 4 pTcosAp r / ori / cm r
/ How to create a neo r shows a.

【図6】図5に続くpTcosApr /ori/cmr
/neor の作成方法を示すものである。
[6] subsequent to FIG. 5 pTcosAp r / ori / cm r
/ How to create a neo r shows a.

【図7】pTcosApr /ori/TK/cmr /n
eor の作成方法を示すものである。
[7] pTcosAp r / ori / TK / cm r / n
This shows how to create eo r .

───────────────────────────────────────────────────── フロントページの続き (72)発明者 岡田 善雄 大阪府箕面市半町2−22−28 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Inventor Yoshio Okada 2-22-28 Hanmachi, Minoh City, Osaka Prefecture

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 同一の方向性を持つたラムダフアージま
たはラムドイドフアージのcosを少なくとも3個有
し、2種類の制限酵素で切ることによつて得られる、そ
れぞれcosを少なくとも1個もしくは2個持つた右腕
と左腕との間に、35〜45Kbpの長さの種々の外来
DNA断片を挿入し、in vitroパツケージング
で形質導入フアージ粒子に変え、次いでラムダフアージ
が溶原化している大腸菌にクローン化したのち誘発をか
けて、組換え体DNAをin vivoパツケージング
で形質導入フアージ粒子に変えることによつて、外来D
NAの遺伝子バンクを製造することを特徴とする新規コ
スミドベクターを用いる遺伝子バンクの製造法。
1. At least three cos of lambda or lambdoid having the same orientation and having at least one or two cos obtained by cutting with two kinds of restriction enzymes. Various foreign DNA fragments with a length of 35 to 45 Kbp were inserted between the right arm and the left arm, which were transformed into transduced sphere particles by in vitro packaging, and then cloned into Escherichia coli lysogenized by lambda phage. Then, by induction, the recombinant DNA is transformed into transduced phagy particles by in vivo packaging to induce the foreign D
A method for producing a gene bank using a novel cosmid vector, which comprises producing an NA gene bank.
【請求項2】 外来DNAが、細菌、糸状菌、酵母など
の微生物、高等動植物もしくは各種フアージ等に由来す
るDNAである請求項1記載の遺伝子バンクの製造法。
2. The method for producing a gene bank according to claim 1, wherein the exogenous DNA is a DNA derived from a microorganism such as a bacterium, a filamentous fungus, a yeast, a higher animal or a plant, various types of phages and the like.
JP9511794A 1994-05-09 1994-05-09 Production of gene bank using new cosmid vector Pending JPH0898690A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9511794A JPH0898690A (en) 1994-05-09 1994-05-09 Production of gene bank using new cosmid vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9511794A JPH0898690A (en) 1994-05-09 1994-05-09 Production of gene bank using new cosmid vector

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59253784A Division JPS61132187A (en) 1984-11-30 1984-11-30 Novel cosmid vector and production of gene bank using same

Publications (1)

Publication Number Publication Date
JPH0898690A true JPH0898690A (en) 1996-04-16

Family

ID=14128903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9511794A Pending JPH0898690A (en) 1994-05-09 1994-05-09 Production of gene bank using new cosmid vector

Country Status (1)

Country Link
JP (1) JPH0898690A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203537A1 (en) * 1982-02-03 1983-08-04 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Method for transferring a specific gene from a genome into Escherichia coli

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3203537A1 (en) * 1982-02-03 1983-08-04 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig Method for transferring a specific gene from a genome into Escherichia coli

Similar Documents

Publication Publication Date Title
Lee et al. Replication deficiencies in priA mutants of Escherichia coli lacking the primosomal replication n'protein.
US4359535A (en) Autonomously replicating DNA containing inserted DNA sequences
JPH0838177A (en) Manufacture of recombination dna molecule
JPS63159397A (en) Recombinant b-type hepatitis virus antigen
WO1992014819A1 (en) A positive selection vector for the bacteriophage p1 cloning system
CN112553238B (en) CRISPR/Cas9 vector applicable to coniothyrium minitans FS482 as well as construction method and application thereof
EP0143841B1 (en) Hybrid viral plasmid and microorganisms containing same
JPH0116159B2 (en)
EP0183571A2 (en) Cosmid vectors
US4393137A (en) Cloning plasmid for streptomyces
CN116004716A (en) Method for efficiently editing genes by using replication dCAS9-FokI system
JPH0898690A (en) Production of gene bank using new cosmid vector
CN108893486A (en) A kind of carrier can be used for filamentous fungi gene knockout and application
AU2022335499A1 (en) Enzymes with ruvc domains
Kobayashi et al. Double Holliday structure: a possible in vivo intermediate form of general recombination in Escherichia coli
JP2003509054A (en) Regulatory sequences and expression cassettes for yeast
Yu et al. A new system to place single copies of genes, sites and lacZ fusions on the Escherichia coli chromosome
JP2599892B2 (en) A method for producing a gene bank using a novel cosmid vector
KR100609565B1 (en) Plant Expression Vector Containing Full Genome of YMV-KYam Mosaic Virus-K
JPS60153792A (en) Host cell of streptomyces having lowered limit activity
CN113564165B (en) Cell strain for intracellular editing of pseudorabies virus key genes, construction method and application thereof
US4663285A (en) Chimeric plasmids
JPH0824580B2 (en) New cosmid vector
CN117106736B (en) Method for constructing three-gene deletion PRV strain by using CBE and application
JP2719534B2 (en) New kind of cloning vector and its production method, DNA-sequence cloning method or gene bank production method